Document:

Exhibit 4.4

 

Execution Version

 

XUNLEI LIMITED

 

FOURTH AMENDED AND RESTATED SHAREHOLDERS AGREEMENT

 

THIS FOURTH AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (this “Agreement”) is made and entered into as of April 14, 2011 by and among (i) Xunlei Limited (formerly known as Giganology Limited), an exempted limited liability company organized under the laws of the Cayman Islands (the “Company”), (ii) Giganology (Shenzhen) Limited, (千兆科技(深圳)有限公司), a wholly foreign-owned enterprise incorporated under the laws of the People’s Republic of China (the “PRC Subsidiary”), and the other entities owned or controlled, directly or indirectly, by the Company listed in Schedule A hereto (the PRC Subsidiary and such other entities collectively, the “Subsidiaries”), (iii) Messrs. Zou Shenglong and Cheng Hao (the “Founders” and each, a “Founder”), (iv) the persons listed in Exhibit A hereto (collectively, the “Series A Investors” and each, a “Series A Investor”), (v) the person(s) listed in Exhibit B hereto (the “Series A-1 Investor”, and together with the Series A Investors, the “2005 Investors”), (vi) the persons listed in Exhibit C hereto (collectively, the “Series B Investors” and each, a “Series B Investor”), and (vii) the person listed in Exhibit D hereto (a “Series C Investor”).  The Series A Investors, Series A-1 Investor, the Series B Investors and the Series C Investor shall collectively be referred to as the “Investors” and individually be referred to as an “Investor”.  The Subsidiaries and the Company shall collectively be referred to as the “Group Companies” and individually be referred to as a “Group Company”.

 

RECITALS

 

A.                                    Pursuant to a Third Amended and Restated Shareholders Agreement dated December 21, 2006 by and among the Company, the Founders, the 2005 Investors and Series B Investors, the parties thereto set forth certain rights of the holders of the Series A-1 Preferred Shares, par value US$0.00025 per share (the “Series A-1 Shares”), Series A Preferred Shares, par value US$0.00025 per share (collectively, the “Series A Shares”) and Series B Preferred Shares, par value US$0.00025 per share (the “Series B Shares”), with respect to, inter alia, certain consent rights, rights of first refusal, co-sale rights and other matters regarding shareholder rights and the Company (the “Third Restated Shareholders Agreement”).

 

B.                                      The Company entered into a Series C Preferred Share Subscription Agreement dated April         , 2011 with the Series C Investor (the “Series C Subscription Agreement”), pursuant to which the Series C Investor have subscribed for an aggregate of 5,728,264 Series C Preferred Shares, par value US$0.00025 per share (the “Series C Shares” and collectively with the Series B Shares, Series A-1 Shares and Series A Shares, the “Preferred Shares”).

 

 

C.                                      The parties hereto desire to enter into this Agreement to amend, restate, supersede and replace in its entirety the Third Restated Shareholders Agreement.

 

D.                                     Pursuant to the Third Restated Shareholders Agreement, any amendment thereto requires written consent of the Company, the holders of a majority of the Preferred Shares and certain other parties thereto affected by such amendment, and the undersigned parties together satisfy such requirements.

 

NOW, THEREFORE, in consideration of the foregoing recitals, the mutual promises hereinafter set forth, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

 

1.                                     INFORMATION RIGHTS; BOARD REPRESENTATION; SHAREHOLDER MEETINGS.

 

1.1                                Information and Inspection Rights.

 

(a)                                   Information Rights. The Company covenants and agrees that, commencing on the date of this Agreement, for so long as an Investor continues to hold five (5) per cent or more of the Shares (as defined below) in issue on an as converted basis, except as otherwise provided in Sections 1.1(b) and (c) below, the Company will deliver to each such Investor (other than Bright Access International Limited):

 

(i)                                      audited annual consolidated financial statements, as soon as practicable but in any event within ninety (90) days after the end of each fiscal year, and audited by a “Big 4” accounting firm chosen by the Company;

 

(ii)                                   unaudited quarterly consolidated and unconsolidated financial statements, as soon as practicable but in any event within forty-five (45) days of the end of each fiscal quarter; and

 

(iii)                                an annual comprehensive operating budget, including but not limited to, a forecast of the Company’s revenues, expenses, and cash position on a month-to-month basis for the following fiscal year, within thirty (30) days prior to the end of each fiscal year (the above rights, collectively, the “Information Rights”);

 

provided that for as long as any Investor or any of its Affiliates is a Competitor (as defined below), the Company shall only be obliged to provide the information described in subsection (i) and (ii) above directly to a duly authorized officer within such Investor’s finance department, subject to such Investor’s undertaking (which shall be deemed to have been given hereunder) that any information received will not be accessed by any person outside such

 

2

 

Investor’s financial department and will only be accessed by members of such Investor’s finance department on a “need to know” basis for the sole purpose of preparing such Investor’s own financial statements and related disclosures and notes.

 

All financial statements to be provided to the Investors pursuant to this Section 1.1 shall include an income statement, a balance sheet and a cash flow statement for the relevant period as well as for the fiscal year to-date and shall be prepared in conformance with the generally accepted accounting principles of the United States of America (“US GAAP”) and shall be provided to the Investors contemporaneously with delivery of such financial statements to the Board.

 

(b)                                  Google’s Information Rights. Notwithstanding subsection (a) above, for as long as Google Inc. (“Google”) holds any Shares, (i) if Google or any Affiliate of Google is not a Competitor, the Company will deliver to Google the financial statements of the Company described in subsections (a)(i) and (a)(ii) above (collectively, the “Financial Statements”) within the respective time periods described therein; and (ii) if Google or any of its Affiliates is a Competitor, the Company will provide the Financial Statements directly to a duly authorized officer within Google’s finance department, subject to Google’s undertaking (which shall be deemed to have been given hereunder) that any information received by Google will not be accessed by any person outside Google’s financial department and will only be accessed by members of Google’s finance department on a “need to know” basis for the sole purpose of preparing Google’s own financial statements and related disclosures and notes. For the purpose of this Agreement, a “Competitor” shall, (A) with respect to any Investor other than Google, be as defined in the Series C Subscription Agreement; and (B) with respect to Google, mean any person (either individual, firm, corporation, partnership, trust, incorporated or unincorporated association, joint venture, joint stock company, limited liability company, or other entity of any kind) that offers a product or service consisting of a client software tool which uses P2SP (Peer to Servers and Peers) technology, including P2MS (Peer to Multi-Servers) technology and enables users to download multi-media files from third party websites.  For greater certainty, none of the products or services currently being offered by Google (or any of its wholly owned subsidiaries, including YouTube, Inc.) or made available on its, or its wholly owned subsidiaries’, websites shall cause Google to be considered a Competitor pursuant to the provisions set forth above.

 

(c)                                   Series C Investor’s Information Rights.  Notwithstanding anything to the contrary, each Series C Investor, for as long as it holds any Shares, shall be entitled to the Information Rights unless and until such Series C Investor holds more than 3% of capital stock calculated on a fully-diluted basis of any company unaffiliated with the Company which, in the good faith reasonable opinion of the Board (as defined below), competes with the Company in the VOD/downloading business in China or any other activity in competition with the Company

 

3

 

in  China, in which case such Series C Investor shall lose, except as required by law, rights to non-public information of the Company.

 

(d)                                  Inspection Rights. The Company further covenants and agrees that, commencing on the date of this Agreement, for so long as a Series A-1 Investor or a Series B Investor continues to hold five (5) per cent or more of the Shares in issue on an as converted basis, such Investor shall have the right (at its expense) to reasonably inspect facilities, records and books of the Company and any of its subsidiaries (including the PRC Subsidiary) at any time during regular working hours on reasonable prior notice to the Company or the PRC Subsidiary, and the right to discuss the business, operation and conditions of the Company and any of its subsidiaries (including the PRC Subsidiary) with their respective directors, officers, employees, accountants, legal counsels and investment bankers (the “Inspection Rights”); provided, however, that the Group Company shall not be obligated pursuant to this Section 1.1(c) to provide access to any information which it reasonably considers to be a trade secret or similar confidential information (unless covered by an enforceable confidentiality agreement, in form and substance reasonably acceptable to the Company), or would adversely affect the attorney-client privilege between the Group Company and its counsel; provided further, that the Inspection Rights of such Investor under this Section 1.2(c) shall terminate if such Investor or any of its Affiliates becomes a Competitor.

 

(e)                                   Termination of Rights.  The Information Rights (including those under subsections (b) and (c)) and Inspection Rights (unless terminated earlier pursuant to subsection (c) above) shall terminate upon the earlier of:

 

(i)                                      the consummation of a firm commitment underwritten public offering by the Company of its common shares (the “Common Shares” and collectively with the Preferred Shares, the “Shares”), on the NASDAQ Global Market, NYSE, or Hong Kong Stock Exchange (main board) (a “Qualified Public Offering”), and provided further that for a period of three (3) years following the consummation of a Qualified Public Offering, the Company shall deliver to each Investor (other than Bright Access International Limited), promptly after filing, copies of the Company’s annual reports, interim reports and/or quarterly reports and all other filings required to be made with the United States Securities and Exchange Commission (“SEC”) or other relevant securities exchange, regulatory authority or governmental agency;

 

(ii)                                   a Trade Sale (as defined below) with gross proceeds to the Company of a minimum of US$200,000,000; or

 

(iii)                                a Liquidation Event or Deemed Liquidation Event, as such terms are defined in the Fourth Amended and Restated Memorandum of Association and Third Amended and Restated Articles of Association of the Company (the “Restated Articles”).

 

4

 

1.2                                Rights of First Notice.

 

(a)                                  Definitions.

 

(i)                                      “Corporate Event” shall mean any of the following, whether accomplished through one or a series of related transactions (a) a sale, lease, transfer or other disposition of all or substantially all of the assets of the Company, (b) a transfer or an exclusive licensing of all or substantially all of the intellectual property of the Company, (c) a sale, transfer or other disposition of a majority of the issued and outstanding share capital of the Company or a majority of the voting power of the Company; or (d) a merger, consolidation or other business combination of the Company with or into any other business entity in which the shareholders of the Company immediately prior to such merger, consolidation or business combination hold shares representing less than a majority of the voting power of the outstanding share capital of the surviving business entity immediately thereafter.

 

(ii)                                   An “Unsolicited Offer” means (a) any bona fide offer in writing for a proposed Corporate Event received from a third party in the absence of any act taken by any employee, agent, officer or director of the Company with the intent of soliciting such offer, and (b) any proposal or offer by the Company to such third party or from such third party for a proposed Corporate Event arising from negotiations that followed the receipt of an offer described in clause (a) above.  Any bona fide offer for a proposed Corporate Event in writing that is not an Unsolicited Offer shall be deemed a “Solicited Offer”.

 

(b)                                 Solicitation of Offers for Corporate Event.

 

(i)                                      Solicitation Notice. The Company agrees that prior to soliciting any offers for a proposed Corporate Event (a “Proposed Event”), the Company will provide Google with five (5) Business Days prior written notice of such intent to solicit offers (a “Solicitation Notice”), specifying the terms and conditions of the Proposed Event, including the proposed selling price for the Company or its assets or proposed licensing price or terms in the event of a license of intellectual property of the Company, the proposed structure of the transaction, a list of the persons from whom the Company in good faith intends to solicit such offers, when the Proposed Event involves an acquisition or license of assets, a description of the assets to be sold or licensed, and the other material terms and conditions of the Proposed Event.

 

(ii)                                   Additional Parties Notice.  The Company agrees that prior to soliciting any offers for the consummation of the Proposed Event described in the Solicitation Notice from any parties that were not listed in the Solicitation Notice (“Additional Parties”), the Company

 

5

 

will provide Google with written notice of such intent to solicit such offers from such Additional Parties.

 

(iii)                                Different Terms and Conditions.  In the event that the Company proposes to accept or approve a Solicited Offer for the consummation of a Proposed Event on terms and conditions that are not substantially the same as the terms and conditions specified in the last Solicitation Notice, the Company agrees to provide Google with a new Solicitation Notice at least three (3) Business Days prior to accepting or approving such Solicited Offer, which includes the information set forth in Section 1.2(b)(i).  Without limiting the generality of the foregoing, a purchase price that is ninety-five percent (95%) or less of the purchase price in the last Solicitation Notice received by Google shall be deemed not to be substantially the same terms and conditions as specified in the last Solicitation Notice.

 

(c)                                  Unsolicited Offers for Corporate Event.

 

(i)                                      If the Company receives an Unsolicited Offer from a third party for a proposed Corporate Event (an “Offered Event”), the Company agrees that it will provide Google, within three (3) Business Days of receiving such Unsolicited Offer, with detailed written notice of the Offered Event specifying the terms and conditions of the Offered Event including the name of such third party, the proposed purchase price for the Company or the assets of the Company or proposed licensing price or terms in the event of a license of intellectual property of the Company, the proposed structure of the Offered Event, when the Offered Event involves an acquisition of assets, a description of the assets to be sold or licensed, and the other material terms and conditions of the Offered Event.

 

(ii)                                   Notwithstanding anything to the contrary herein, if the Company receives an unwritten unsolicited offer from a third party for an Offered Event and a meeting of the Company’s Board of Directors is called to consider such unwritten unsolicited offer, the Company agrees that it will provide Google, at least three (3) Business Days prior to such meeting, with detailed written notice of the Offered Event, which includes the information set forth in Section 1.2(c)(i).

 

(iii)                                The Company shall not, without providing Google with prior written notice at least five (5) Business Days in advance, accept or approve the Offered Event or recommend that its shareholders approve the Offered Event.

 

(d)                                  Termination of Rights. The rights set forth in Sections 1.2(b) and 1.2(c) shall terminate upon the earlier of:

 

(i)                                    closing of a Qualified Public Offering; or

 

6

 

(ii)                                   a Liquidation Event or Deemed Liquidation Event, as such terms are defined in the Restated Articles.

 

1.3                                Board Representation of the Company.

 

(a)                                   Number of Directors. The Restated Articles shall provide that the Company’s Board of Directors (the “Board”) shall consist of five (5) members, which number of members shall not be changed except pursuant to an amendment to the Restated Articles. Except as set forth in this Section 1.3, the Company shall not grant any additional Board seats or Board observer rights without the prior written consent of the Investors.

 

(b)                                  Election of Directors.  The Company shall take all action necessary to elect the following candidates as directors:

 

(i)                                      For as long as the Series B Investors continue to hold ten percent (10%)  or more of the Shares in issue, the holders of a majority of the Series B Shares shall be entitled to appoint and remove one (1) of the five voting Directors of the Board (the “Series B Director”).  For as long as the Series B Investors continue to hold ten percent (10%) or more of the Shares in issue the number of Directors to be appointed by the Series B Investors shall not fall below one (1), and the Series B Investors shall have the exclusive right to remove and replace any Series B Director by notice in writing to the Company.

 

(ii)                                   For as long as the Series A-1 Investor continues to hold fifteen percent (15%) or more of the Shares in issue, the Series A-1 Investor shall be entitled to appoint and remove one (1) of the five voting Directors of the Board (the “Series A-1 Director”), who shall initially be Mr. Liu Qin.  For as long as the Series A-1 Investor continues to hold fifteen percent (15%) or more of the Shares in issue the number of Directors to be appointed by the Series A-1 Investor shall not fall below one (1), and the Series A-1 Investor shall have the exclusive right to remove and replace any Series A-1 Director by notice in writing to the Company.  For as long as the Series A-1 Investor continues to hold fifteen percent (15%) or more of the Shares in issue, the Series A-1 Investor shall have the right to appoint and remove one (1) observer of the Board, who may participate in discussions of matters brought before the Board, but shall in all other respects be a nonvoting observer.

 

(iii)                                The Founders shall, for so long as they together continue to hold twenty (20) per cent or more of the Shares in issue (including the Shares underlying the Founder Options, if exercised) shall be entitled to appoint and remove two (2) of the five voting Directors of the Board (the “Founder Directors”) and shall have the exclusive right to remove and replace any Founder Directors so appointed by notice in writing to the Company.

 

7

 

(iv)                               For as long as the Series A Investors continue to hold fifteen percent (15%) or more of the Shares in issue, the holders of a majority of the Series A Shares shall be entitled to appoint and remove one (1) of the five (5) voting Directors of the Board (the “Series A Director”), who shall initially be Mr. Zhou Quan.  For as long as the Series A Investors continues to hold fifteen percent (15%) or more of the Shares in issue the number of Directors to be appointed by the Series A Investor shall not fall below one (1), and the Series A Investor shall have the exclusive right to remove and replace any Series A Director by notice in writing to the Company.

 

Provided that, if any Director (“Defaulting Director”) appointed pursuant to Section 1.3(b)(i), Section 1.3(b)(ii) or Section 1.3(b)(iv) carries on, engages in or is concerned or interested in, directly or indirectly, either as principal or agent or as a shareholder, partner, consultant, advisor, director, officer or employee, or in any other capacity, any activities of any Competitors, or seeks, attempts or threatens to do any of the foregoing, a majority of the holders of the Preferred Shares other than the holders appointing such Defaulting Director shall be entitled to request in writing the Board to, and upon receipt of such request, the Board shall, remove such Defaulting Director by action of the majority of the rest of the Directors appointed to the Board in accordance with the terms of this Section 1.3. The holders of Preferred Shares appointing the Defaulting Director and the Defaulting Director shall abstain from voting on any proposal to remove the Defaulting Director pursuant to the foregoing provision of this Section 1.3.

 

(c)                                   Board Committees.  Each committee of the Board and the quorum for such committee shall consist of at least the Series B Director.

 

(d)                                  Quorum and Notice. A quorum of the Board shall consist of four (4) directors. In relation to meetings of the Board, a director shall be given not less than ten (10) Business Days’ written notice of meetings, but any meeting held without ten (10) Business Days’ written notice having been given to all directors shall be valid if all the directors entitled to vote at the meeting waive notice of the meeting in writing; and for this purpose, the presence of a director at a meeting shall be deemed to constitute a waiver on his part in respect of such meeting.  A director may attend meetings of the Board in person or by telephone.

 

(e)                                   Board Meetings. The Board shall meet at least once every six (6) months, unless otherwise agreed by a vote of a majority of the Board, including the vote of the Series B Director and one (1) Series A-1 Director.

 

(f)                                     Expenses and Insurance.  The Company shall reimburse the directors appointed by the holders of Preferred Shares for all reasonable expenses relating to all Board activities,

 

8

 

including, without limitation, expenses or fees incurred in relation to attending the Board meetings or meetings of any committee.  The Company shall purchase and at all times maintain director’s and officer’s indemnity insurance policies for the benefit of the Directors on terms and in amounts approved by the Board.

 

(h)                                  Indemnity of Directors and Legal Representative. The Company shall indemnify each Director and the Legal Representative of the Group Companies to the greatest extent permissible by applicable law in respect of any liabilities incurred in such capacity as a Director or Legal Representative of the relevant Group Company apart from those arising from gross negligence and willful misconduct. The Company shall enter into an indemnification agreement with each Director and the Legal Representative of each Subsidiary in the form attached hereto as Exhibit F.

 

1.4                                 Board Representation of the PRC Subsidiary. The board of directors of the PRC Subsidiary (the “Subsidiary Board”) shall have the same number of directors as, and the Founders and holders of Preferred Shares shall be entitled to appoint the same number of directors to the PRC Subsidiary as they are entitled to appoint to the Company as provided in Section 1.3 above.

 

1.5                                 Board Management. Except as specifically provided herein or by applicable laws, the management and control of the Company and each other Group Company shall be exercised by the Board and the board of directors of the applicable Subsidiary, and the Board shall be responsible for the determination of the Group Companies’ overall policies and objects.

 

1.6                                 Shareholder Meetings.

 

(a)                                   The Board shall give not less than seven (7) Business Days’ (as defined below) notice of meetings of holders of Shares of the Company (“Shareholders”) to those persons whose names on the date the notice is given appear as Shareholders in the register of members of the Company and are entitled to vote at the meeting.

 

(b)                                  The parties hereto agree that no meeting of Shareholders of the Company shall be a quorum unless (i) a minimum of three (3) Shareholders, (ii) a representative of the Founders, (iii) a representative of the Series A-1 Investor, and (iv) a representative of the holders of a majority in interest of the Series B Investors.

 

(c)                                   In a meeting of Shareholders of the Company, each Preferred Share shall carry such number of votes as is equal to the number of votes then issuable upon the conversion of such Preferred Shares into Common Shares (as defined in the Restated Articles).  Each holder of Common Shares shall have one (1) vote for each Common Share held by such holder. The

 

9

 

holders of Preferred Shares and the holders of common shares, par value US$0.00025 per share, of the Company shall vote together and not as a separate class, except as otherwise required by this Agreement or the Restated Articles.

 

(d)                                  Termination of Rights. The rights set forth in Sections 1.3, 1.4, 1.5 and 1.6 shall terminate upon the earlier of:

 

(i)                                     closing of a Qualified Public Offering; or

 

(ii)                                   a Liquidation Event or Deemed Liquidation Event, as such terms are defined in the Restated Articles.

 

(e)                                  Dual Class Voting Structure after the Company’s initial public offering.  All parties to this Agreement agree to implement a dual class structure for the Company (“Dual Class Structure”) immediately prior to the completion of the Company’s initial public offering.  Pursuant to the Dual Class Structure, the existing common shares and common shares that the preferred shares will automatically convert into immediately prior to the Company’s Qualified Public Offering will be re-designated into Class A common shares or Class B common shares in accordance with the key terms of the Dual Class Structure as set out in Exhibit G..  All parties to this Agreement hereby undertake to pass all requisite resolutions approving, and vote in favor of, an Amended Memorandum and Articles of Association of the Company that reflect and implement the Dual Class Structure, and the applicable share conversion and re-designation mechanism under Cayman Islands law to implement Section 1 and Section 2, Table of Dual-class Voting Structure, in Exhibit G.

 

2.                                     REGISTRATION RIGHTS.

 

2.1                                 Applicability of Rights. The Company covenants and agrees that the Holders (as defined below) shall be entitled to the following rights with respect to any potential public offering of the Company’s Shares in the United States and shall be entitled to reasonably analogous or equivalent rights with respect to any other offering of the Company’s securities in any other jurisdiction in which the Company undertakes to publicly offer or list such securities for trading on a recognized securities exchange.

 

2.2                                 Definitions. For purposes of this Section 2 and to the extent applicable under this Agreement:

 

(a)                                   Registration. The terms “register,” “registered,” and “registration” refer to a registration effected by filing a registration statement which is in a form which complies with, and is declared effective by the SEC (as defined below) in accordance with, the Securities Act.

 

10

 

(b)                                  Registrable Securities. The term “Registrable Securities” shall mean: (i) any Common Shares of the Company issued or issuable upon conversion of any shares of the Preferred Shares (the “Conversion Shares”) (A) under that certain Subscription Agreement dated as of September 16, 2005 between the Company, the Founders and the 2005 Investors (the “Series A Subscription Agreement”), the Subscription Agreement dated as of November 15, 2006 between the Group Companies, the Founders and the Series B Investors (other than Fidelity Asia Ventures Fund L.P. and Fidelity Asia Principals Fund L.P. (collectively, “Fidelity”) and Google), (the “Series B Subscription Agreement”), certain Applications for Shares signed by Google on December 9, 2006 and by Fidelity on December 21, 2006, and the Series C Subscription Agreement respectively, and (B) pursuant to the Right of Participation (defined in Section 3 hereof), and (ii) any Common Shares of the Company issued (or issuable upon the conversion or exercise of any warrant, right or other security which is issued) as a dividend or other distribution with respect to, or in exchange for or in replacement of, any Preferred Shares or Common Shares described in clause (i) of this subsection (b); provided that, with respect to any provision under the Section 2.3 below, the “Registrable Securities” shall exclude the Common Shares of the Company issued or issuable upon conversion of the Series C Shares.  Notwithstanding the foregoing, “Registrable Securities” shall exclude any Registrable Securities sold by a person in a transaction in which rights under this Section 2 are not assigned in accordance with this Agreement, and any Registrable Securities which are sold in a registered public offering under the Securities Act or analogous statute of another jurisdiction, or sold pursuant to Rule 144 promulgated under the Securities Act or analogous rule of another jurisdiction.

 

(c)                                   Registrable Securities Then Outstanding. The number of shares of “Registrable Securities then outstanding” shall mean the number of Common Shares of the Company that are Registrable Securities and are then issued and outstanding, issuable upon conversion of Preferred Shares then issued and outstanding or issuable upon conversion or exercise of any warrant, right or other security then outstanding.

 

(d)                                  Holder. For purposes of this Section 2, the term “Holder” shall mean any person or persons owning or having the rights to acquire Registrable Securities or any permitted assignee of record of such Registrable Securities to whom rights under this Section 2 have been duly assigned in accordance with this Agreement, however provided that with respect to Section 2.3, the “Holders” shall exclude the holders of any Common Shares of the Company issued or issuable upon conversion of any shares of the Preferred Shares under the Series C Subscription Agreement.

 

(e)                                   Form F-3. The term “Form F-3” shall mean such respective form under the Securities Act as is in effect on the date hereof or any successor registration form under the

 

11

 

Securities Act subsequently adopted by the SEC which permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC.

 

(f)                                     SEC. The term “SEC” or “Commission” shall mean (i) with respect to any offering of securities in the United States, the U.S. Securities and Exchange Commission or any other federal agency at the time administering the Securities Act and (ii) with respect to any offering of securities in a jurisdiction other than the United States, the regulatory body of the jurisdiction with authority to supervise and regulate the sale of securities in that jurisdiction.

 

(g)                                  Registration Expenses. The term “Registration Expenses” shall mean all expenses incurred by the Company in complying with Sections 2.3, 2.4 and 2.5 hereof, including, without limitation, all registration and filing fees, printing expenses, fees, and disbursements of counsel for the Company, reasonable fees and disbursements of one counsel for the Holders, Blue Sky fees and expenses and the expense of any special audits incident to or required by any such registration (but excluding the compensation of regular employees of the Company which shall be paid in any event by the Company).

 

(h)                                  Selling Expenses. The term “Selling Expenses” shall mean all underwriting discounts and selling commissions applicable to the sale of Registrable Securities pursuant to Sections 2.3, 2.4 and 2.5 hereof.

 

(i)                                      Exchange Act. The term “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and any successor statute.

 

(j)                                      For purposes of this Agreement, reference to registration of securities under the Securities Act and the Exchange Act shall also be deemed to mean the equivalent registration in a jurisdiction other than the United States as designated by such Holders, it being understood and agreed that in each such case all references in this Agreement to the Securities Act, the Exchange Act and rules, forms of registration statements and registration of securities thereunder, U.S. law and the SEC, shall be deemed to refer, to the equivalent statutes, rules, forms of registration statements, registration of securities and laws of and equivalent government authority in the applicable non-U.S. jurisdiction.

 

(k)                                   Business Days.  The term “Business Day” means any day (excluding Saturdays, Sundays and public holidays in Hong Kong and New York) on which banks generally are open for business in Hong Kong and New York.

 

2.3                                Demand Registration.

 

(a)                                   Request by Holders. If at any time after six (6) months following the closing of

 

12

 

the Company’s first firm commitment underwritten public offering the Company shall receive a written request from the Holders of at least twenty-five percent (25%) of the Registrable Securities to file a registration statement under the Securities Act covering the registration of Registrable Securities pursuant to this Section 2.3, the Company shall, within ten (10) Business Days of the receipt of such written request, give written notice of such request (the “Request Notice”) to all Holders, and use its best efforts to effect, as soon as practicable, the registration under the Securities Act of all Registrable Securities that the Holders request to be registered and included in such registration by written notice given by such Holders to the Company within twenty (20) days after receipt of the Request Notice, subject only to the limitations of this Section 2.3; provided that the Company shall not be obligated to effect, or to take any action to effect, any such registration if:

 

(i)                                      In any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting such registration, qualification, or compliance, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act;

 

(ii)                                   After the Company has initiated three (3) such registrations pursuant to this section (counting for these purposes only registrations which have been declared or ordered effective);

 

(iii)                                During the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of filing of, and ending on a date one hundred eighty (180) days after the effective date of, a Company-initiated registration; provided that the Company is actively employing in good faith all reasonable efforts to cause such registration statement to become effective;

 

(iv)                               If the Initiating Holders (defined below) propose to dispose of Registrable Securities which may be immediately registered on Form F-3 pursuant to a request made under section 4 hereof;

 

(v)                                  If the Initiating Holders (defined below) do not request that such offering be firmly underwritten by underwriters selected by the Initiating Holders (subject to the consent of the Company, which consent will not be unreasonably withheld); or

 

(vi)                               If the Company and the Initiating Holders (defined below) are unable to obtain the commitment of the underwriter described in clause (v) above to firmly underwrite the offer.

 

13

 

(b)                                  Underwriting. If the Holders initiating the registration request under this Section 2.3 (the “Initiating Holders”) intend to distribute the Registrable Securities covered by their request by means of an underwriting, then they shall so advise the Company as a part of their request made pursuant to this Section 2.3 and the Company shall include such information in the Request Notice.  In such event, the right of any Holder to include its Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed by a majority in interest of the Initiating Holders and such Holder) to the extent provided herein.  All Holders proposing to distribute their Registrable Securities through such underwriting shall enter into an underwriting agreement in customary form with the managing underwriter or underwriters selected for such underwriting by the Holders of a majority of the Registrable Securities being registered and reasonably acceptable to the Company.  Notwithstanding any other provision of this Section 2.3, if the underwriter(s) advise(s) the Company in writing that marketing factors require a limitation of the number of securities to be underwritten, then the Company shall so advise all Holders which would otherwise be registered and underwritten pursuant hereto, and the number of Registrable Securities that may be included in the underwriting shall be reduced as required by the underwriter(s) and allocated among the Holders on a pro rata basis according to the number of Registrable Securities then outstanding held by each Holder requesting registration (including the Initiating Holders); provided, however, that the number of shares of Registrable Securities held by holder(s) of the Series A Shares, the Series A-1 Shares and Series B Shares to be included in such underwriting and registration shall not be reduced unless all other securities are first entirely excluded from the underwriting and registration including, without limitation, all shares that are not Registrable Securities and are held by any other person, including, without limitation, any person who is an employee, consultant, officer or director of the Company or any subsidiary of the Company; provided further that at least twenty-five (25%) of shares of Registrable Securities requested by the Holders to be included in such underwriting and registration shall be so included. If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the Company and the underwriter(s), delivered at least ten (10) Business Days prior to the effective date of the registration statement. Any Registrable Securities excluded or withdrawn from such underwriting shall be excluded and withdrawn from the registration.

 

(c)                                   Maximum Number of Demand Registrations. The Company shall not be obligated to effect more than three (3) such demand registrations pursuant to this Section 2.3.

 

(d)                                  Deferral. Notwithstanding the foregoing, if the Company shall furnish to Holders requesting registration pursuant to this Section 2.3, a certificate signed by the President or Chief Executive Officer of the Company stating that in the good faith judgment of the Board, it would be materially detrimental to the Company and its shareholders for such registration statement to be filed at such time, then the Company shall have the right to defer such filing for a period of

 

14

 

not more than one hundred and twenty (120) days after receipt of the request of the Initiating Holders; provided, however, that the Company may not utilize this right more than once in any twelve (12) month period; provided further, that the Company shall not register any other of its shares during such twelve (12) month period.  A demand right shall not be deemed to have been exercised until such deferred registration shall have been effected.

 

(e)                                   Other Securities Laws in Demand Registration.  In the event of any registration pursuant to this Section 2.3, the Company shall register and qualify the securities covered by the registration statement under the securities laws of any other jurisdictions outside of the United States or in Hong Kong or elsewhere as shall be appropriate for the distribution of the securities; provided, however, that (i) the Company shall not be required to do business or to file a general consent to service of process in any such state or jurisdiction, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act, and (ii) notwithstanding anything in this Agreement to the contrary, in the event any jurisdiction in which the securities shall be qualified imposes a non-waivable requirement that expenses incurred in connection with the qualification of the securities be borne by selling shareholders, the expenses shall be payable pro rata by the selling shareholders.

 

2.4                                Piggyback Registrations.

 

(a)                                   The Company shall notify all Holders in writing at least thirty (30) days prior to filing any registration statement under the Securities Act for purposes of effecting a public offering of securities of the Company (including, but not limited to, registration statements relating to secondary offerings of securities of the Company, but excluding registration statements relating to any registration under Section 2.3 or Section 2.5 of this Agreement or to any employee benefit plan or a corporate reorganization or other Rule 145 transaction, an offer and sale of debt securities, or a registration on any registration form that does not permit secondary sales, or the Company’s initial public offering of its common shares), and shall afford each such Holder an opportunity to include in such registration statement all or any part of the Registrable Securities then held by such Holder.  Each Holder desiring to include in any such registration statement all or any part of the Registrable Securities held by it shall within twenty (20) days after receipt of the above-described notice from the Company, so notify the Company in writing, and in such notice shall inform the Company of the number of Registrable Securities such Holder wishes to include in such registration statement.  If a Holder decides not to include all of its Registrable Securities in any registration statement thereafter filed by the Company, such Holder shall nevertheless continue to have the right to include any Registrable Securities in any subsequent registration statement or registration statements as may be filed by the Company with respect to offerings of its securities, all upon the terms and conditions set forth herein.

 

15

 

(b)                                  Underwriting. If a registration statement for which the Company gives notice under this Section 2.4 is for an underwritten offering, then the Company shall so advise the Holders.  In such event, the right of any such Holder’s Registrable Securities to be included in a registration pursuant to this Section 2.4 shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their Registrable Securities through such underwriting shall enter into an underwriting agreement in customary form with the managing underwriter or underwriters selected for such underwriting.  Notwithstanding any other provision of this Agreement but subject to Section 2.12, if the managing underwriter(s) determine(s) in good faith that marketing factors require a limitation of the number of shares to be underwritten, then the managing underwriter(s) may exclude Registrable Securities requested to be registered from the registration and the underwriting, and the number of Registrable Securities that may be included in the registration and the underwriting shall be allocated, first, to the Company, second, to the holders of Series C Shares, Series B Shares and Series A-1 Shares holding the Registrable Securities on a pro rata basis, third, to each of the remaining Holders requesting inclusion of their Registrable Securities in such registration statement on a pro rata basis, in each case based on the total number of shares of Registrable Securities then held by each such Holder , and fourth to holders of other securities of the Company; provided, however, that the right of the underwriter(s) to exclude shares (including Registrable Securities) from the registration and underwriting as described above shall be restricted so that (i) the number of Registrable Securities held by holder(s) of the Series C Shares, Series B Shares and Series A-1 Shares included in any such registration is not reduced below twenty-five percent (25%) of the aggregate number of shares of Registrable Securities for which inclusion has been requested; and (ii) all shares of Registrable Securities held by holder(s) of the Series A Shares or all other shares that are not Registrable Securities and are held by any other person, including, without limitation, any person who is an employee, consultant, officer or director of the Company (or any subsidiary of the Company) shall first be excluded from such registration and underwriting before any Registrable Securities held by holder(s) of the Series C Shares and Series B Shares are so excluded.  If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the Company and the underwriter(s), delivered at least ten (10) Business Days prior to the effective date of the registration statement.  Any Registrable Securities excluded or withdrawn from such underwriting shall be excluded and withdrawn from the registration.

 

(c)                                   Not Demand Registration. Registration pursuant to this Section 2.4 shall not be deemed to be a demand registration as described in Section 2.3 above.  There shall be no limit on the number of times the Holders may request registration of Registrable Securities under this Section 2.4.

 

16

 

2.5                                 Form F-3 Registration.  In case the Company shall receive from any Holder or Holders of at least thirty-three percent (33%) of the Registrable Securities then outstanding a written request or requests that the Company effects a registration on Form F-3 (or an equivalent registration in a jurisdiction outside of the United States) and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or Holders, then the Company will:

 

(a)                                   Notice. Promptly give written notice of the proposed registration and the Holder’s or Holders’ request therefor, and any related qualification or compliance, to all other Holders; and

 

(b)                                  Registration. As soon as practicable, effect such registration and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holder’s or Holders’ Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities of any other Holder or Holders joining in such request as are specified in a written request given within twenty (20) days after the Company provides the notice contemplated by Section 2.5(a); provided, however, that the Company shall not be obligated to effect any such registration, qualification or compliance pursuant to this Section 2.5:

 

(i)                                    if Form F-3 is not available for such offering by the Holders;

 

(ii)                                   if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public of less than US$1,000,000;

 

(iii)                                if the Company shall furnish to the Holders a certificate signed by the President or Chief Executive Officer of the Company stating that in the good faith judgment of the Board, it would be materially detrimental to the Company and its shareholders for such Form F-3 registration to be effected at such time, in which event the Company shall have the right to defer the filing of the Form F-3 registration statement no more than once during any twelve (12) month period for a period of not more than ninety (90) days after receipt of the request of the Holder or Holders under Section 2.5(a); provided that the Company shall not register any of its other shares during such ninety (90) day period;

 

(iv)                               if the Company has, within the six (6) month period preceding the date of such request, already effected a registration under the Securities Act other than a registration from which the Registrable Securities of Holders have been excluded (with respect to all or any portion of the Registrable Securities the Holders requested be included in such registration) pursuant to the provisions of Sections 2.3(b) and 2.4(b); or

 

17

 

(v)                                  in any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to service of process in effecting such registration, qualification or compliance, unless the Company is already subject to service of process in such jurisdiction; or

 

(vi)                               if such registration is to be effected more than five (5) years after the Company’s initial public offering.

 

(c)                                   Not Demand Registration. Form F-3 registrations shall not be deemed to be demand registrations as described in Section 2.3 above. Except as otherwise provided herein, there shall be no limit on the number of times the Holders may request registration of Registrable Securities under this Section 2.5.

 

(d)                                  Underwriting.  If the Holders requesting registration under this Section 2.5 intend to distribute the Registrable Securities covered by their request by means of an underwriting, the provisions of Section 2.3(b) shall apply to such registration.

 

2.6                                 Expenses. All Registration Expenses incurred in connection with any registration pursuant to Section 2.3, 2.4 or 2.5 (but excluding Selling Expenses) shall be borne by the Company.  Each Holder participating in a registration pursuant to Section 2.3, 2.4 or 2.5 shall bear such Holder’s proportionate share (based on the total number of shares sold in such registration other than for the account of the Company) of all Selling Expenses or other amounts payable to underwriter(s) or brokers, in connection with such sale by the Holders. Notwithstanding the foregoing, the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 2.3 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered, unless the Holders of a majority of the Registrable Securities then outstanding agree that such registration constitutes the use by the Holders of one (1) demand registration pursuant to Section 2.3 (in which case such registration shall also constitute the use by all Holders of one (1) such demand registration); provided further, however, that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business, or prospects of the Company not known to the Holders at the time of their request for such registration and have withdrawn their request for registration with reasonable promptness after learning of such material adverse change, then the Holders shall not be required to pay any of such expenses and such registration shall not constitute the use of a demand registration pursuant to Section 2.3.

 

18

 

2.7                                 Obligations of the Company. Whenever required to effect the registration of any Registrable Securities under this Agreement, the Company shall, as expeditiously as reasonably possible:

 

(i)                                      Registration Statement. Prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its best efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for a period of up to ninety (90) days; provided, however, that (i) such ninety (90) day period shall be extended for a period of time equal to the period any Holder refrains from selling any securities included in such registration at the request of the underwriter(s), and (ii) in the case of any registration of Registrable Securities on Form F-3 which are intended to be offered on a continuous or delayed basis, such ninety (90) day period shall be extended, if necessary, to keep the registration statement effective until all such Registrable Securities are sold.

 

(ii)                                   Amendments and Supplements. Prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement.

 

(iii)                                Prospectuses. Furnish to the Holders such number of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of the Registrable Securities owned by them that are included in such registration.

 

(iv)                               Blue Sky. Use its best efforts to register and qualify the securities covered by such registration statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction or except as may be required by the Securities Act.

 

(v)                                  Underwriting. In the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement in usual and customary form, with the managing underwriter(s) of such offering.

 

(vi)                               Notification. Notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of (i) the issuance of any stop order by the SEC in respect of such registration statement, or (ii) the happening of any event as a result of which the prospectus

 

19

 

included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing.

 

(vii)                            Opinion and Comfort Letter.  Furnish, at the request of any Holder requesting registration of Registrable Securities, on the date that such Registrable Securities are delivered to the underwriter(s) for sale, if such securities are being sold through underwriters, or, if such securities are not being sold through underwriters, on the date that the registration statement with respect to such securities becomes effective, (i) an opinion, dated as of such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering and reasonably satisfactory to a majority in interest of the Holders requesting registration, addressed to the underwriters, if any, and to the Holders requesting registration of the Registrable Securities and (ii) letters dated as of (x) the effective date of the registration statement covering such Registrable Securities and (y) the closing date of the offering from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering and reasonably satisfactory to a majority in interest of the Holders requesting registration, addressed to the underwriters, if any, and to the Holders requesting registration of the Registrable Securities.

 

2.8                                 Furnish Information.  It shall be a condition precedent to the obligations of the Company to take any action pursuant to Section 2.3, 2.4 or 2.5 that the selling Holders shall furnish to the Company such information regarding themselves, the Registrable Securities held by them and the intended method of disposition of such securities as shall be required to timely effect the registration of their Registrable Securities.

 

2.9                                 Indemnification.  In the event any Registrable Securities are included in a registration statement under Section 2.3, 2.4 or 2.5:

 

(a)                                   By the Company. To the extent permitted by law, the Company will indemnify and hold harmless each Holder, its partners, officers, directors, legal counsel, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Securities Act, the Exchange Act, or other United States federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”):

 

20

 

(i)                                      any untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus, final prospectus or free-writing prospectus contained therein or any amendments or supplements thereto;

 

(ii)                                   any omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading; or

 

(iii)                                any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any United States federal or state securities law, or any rule or regulation promulgated under the Securities Act, the Exchange Act, or any United States federal or state securities law in connection with the offering covered by such registration statement;

 

the Company will reimburse each such Holder, its partner, officer, director, legal counsel, underwriter or controlling person for any legal or other expenses reasonably incurred by them, as incurred, in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained in this subsection (a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the written consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration by such Holder, partner, officer, director, legal counsel, underwriter or controlling person of such Holder.

 

(b)                                  By Selling Holders. To the extent permitted by law, each selling Holder will, if Registrable Securities held by such Holder are included in the securities as to which such registration qualifications or compliance is being effected, indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, its legal counsel, each person, if any, who controls the Company within the meaning of the Securities Act, any underwriter and any other Holder selling securities under such registration statement or any of such other Holder’s partners, directors, officers, legal counsel or any person who controls such Holder within the meaning of the Securities Act or the Exchange Act, against any losses, claims, damages or liabilities (joint or several) to which the Company or any such director, officer, legal counsel, controlling person, underwriter or other such Holder, partner, director, officer, legal counsel or controlling person of such other Holder may become subject under the Securities Act, the Exchange Act or other United States federal or state law, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly for use in connection with such registration; and each such Holder will reimburse any legal or

 

21

 

other expenses reasonably incurred by the Company or any such director, officer, legal counsel, controlling person, underwriter or other Holder, partner, officer, director, legal counsel or controlling person of such other Holder in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained in this Section 2.9(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the written consent of such Holder, which consent shall not be unreasonably withheld; and provided, further, that in no event shall any indemnity under this Section 2.9(b) exceed the net proceeds actually received by such Holder in the registered offering out of which the applicable Violation arises.

 

(c)                                   Notice. Promptly after receipt by an indemnified party under this Section 2.9 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 2.9, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party shall have the right to retain its own counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential conflict of interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall relieve such indemnifying party of liability to the indemnified party under this Section 2.9 to the extent the indemnifying party is materially prejudiced as a result thereof, but the omission to so deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 2.9.

 

(d)                                  Contribution. In order to provide for just and equitable contribution to joint liability under the Securities Act in any case in which either (i) any indemnified party makes a claim for indemnification pursuant to this Section 2.9 but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this Section 2.9 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any indemnified party in circumstances for which indemnification is provided under this Section 2.9; then, and in each such case, the indemnified party and the indemnifying party will contribute to the aggregate losses, claims, damages or liabilities to which they may be subject (after contribution from others) in such proportion to reflect the relative fault of the indemnifying party, on the one hand, and the indemnified party, on the other hand, in connection with the Violation that resulted in such losses,

 

22

 

claims, damages or liabilities so that a Holder at such fault (together with its related persons) is responsible for the portion represented by the percentage that the public offering price of its Registrable Securities offered by and sold under the registration statement bears to the public offering price of all securities offered by and sold under such registration statement, and the Company and other selling Holders at such fault are responsible for the remaining portion.  The relative fault of the indemnifying party and of the indemnified party shall be determined by a court of law by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission; provided, however, that, in any such case: (A) no Holder will be required to contribute any amount in excess of the net proceeds to such Holder from the sale of all such Registrable Securities offered and sold by such Holder pursuant to such registration statement; and (B) no person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person or entity who was not guilty of such fraudulent misrepresentation.

 

(e)                                   Survival; Consents to Judgments and Settlements. The obligations of the Company and Holders under this Section 2.9 shall survive the completion of any offering of Registrable Securities in a registration statement, regardless of the expiration of any statutes of limitation or extensions of such statutes.  No indemnifying party, in the defense of any such claim or litigation, shall, except with the consent of each indemnified party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

 

2.10                           Termination of the Company’s Obligations. The Company’s obligations under Section 2.4 with respect to any Registrable Securities proposed to be sold by a Holder in a registration pursuant to Section 2.4 shall terminate on the second (2nd) anniversary of a Qualified Public Offering.  The Company’s obligations under Sections 2.3 and 2.5 with respect to any Registrable Securities proposed to be sold by a Holder in a registration pursuant to Section 2.3 or 2.5 shall terminate on the fifth (5th) anniversary of a Qualified Public Offering, or, if, in the opinion of counsel to the Company, all such Registrable Securities proposed to be sold by a Holder (and any Affiliate of the Holder with whom such Holder must aggregate its sales under Rule 144) may then be sold without restrictions pursuant to Rule 144 promulgated under the Securities Act.

 

2.11                           No Registration Rights to Third Parties. Without the prior written consent of the holders of a majority of the Series A-1 Shares then outstanding, the holders of a majority of Series B Shares then outstanding and the holders of a majority of the Series C Shares then outstanding, in

 

23

 

each case voting together as a separate class, the Company covenants and agrees that it shall not grant, or cause or permit to be created, for the benefit of any person or entity any registration rights of any kind (whether similar to the demand, “piggyback” or Form F-3 registration rights described in this Section 2, or otherwise) relating to any securities of the Company.

 

2.12                           Market Stand-Off.  Each holder of the Common Shares and each Holder agree that, so long as it holds any voting securities of the Company, upon request by the Company or the underwriters managing the initial public offering of the Company’s securities, it will not sell or otherwise transfer or dispose of any securities of the Company (other than those permitted to be included in the registration and other transfers to Affiliates permitted by law or to other Affiliates who agree to be similarly bound) without the prior written consent of the Company or such underwriters, as the case may be, for a period of time specified by the representative of the underwriters not to exceed one hundred and eighty (180) days from the effective date of the registration statement covering such initial public offering or the pricing date of such offering as may be requested by the underwriters (whichever is later).  The foregoing provision of this Section 2.12 shall only apply to the Company's initial public offering and shall not apply to the sale of any securities of the Company to an underwriter pursuant to any underwriting agreement, and shall only be applicable to the Holders if all officers, directors and holders of one percent (1%) or more of the Company’s outstanding share capital on a fully-diluted basis enter into similar agreements with same terms and conditions as described in this Section 2.12, and if the Company or any underwriter releases, at any time during the market stand-off time period, any officer, director or holder of one percent (1%) or more of the Company’s outstanding share capital on a fully-diluted basis from his, her or its sale restrictions so undertaken, then each Holder shall be notified prior to such release and shall itself be simultaneously released to the same proportional extent of such Holder’s Shares originally subject to the market-standoff restrictions.  The Company shall require all future acquirers of the Company’s securities holding at least one percent (1%) of the then outstanding share capital of the Company on a fully-diluted basis to execute, prior to any public offering of the Company’s securities, a market stand-off agreement containing substantially similar provisions as those contained in this Section 2.12.

 

2.13                           Rule 144 Reporting. With a view to making available to the Holders the benefits of certain rules and regulations of the SEC which may at any time permit the sale of the Registrable Securities to the public without registration or pursuant to a registration on Form F-3, after such time as a public market exists for the Common Shares, the Company agrees to:

 

(a)                                   Make and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act, at all times after the effective date of the first registration under the Securities Act filed by the Company for an offering of its securities to the general public;

 

24

 

(b)                                  File with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements); and

 

(c)                                   So long as a Holder owns any Registrable Securities, furnish to such Holder forthwith upon request (i) a written statement by the Company as to its compliance with the reporting requirements of Rule 144 (at any time after ninety (90) days after the effective date of the Company's initial public offering), the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements), or its qualification as a registrant whose securities may be resold pursuant to Form F-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company, and (iii) such other reports and documents of the Company as a Holder may reasonably request in availing itself of any rule or regulation of the SEC that permits the selling of any such securities without registration or pursuant to Form F-3.

 

3.                                     RIGHT OF FIRST OFFER.

 

3.1                                 General.  Each Investor and its permitted assignees to whom such Investor’s rights under this Section 3 have been duly assigned in accordance with Section 6.1 (such Investor, and each such assignee hereinafter each referred to as a “Participation Rights Holder”) shall have the right of first offer, but not an obligation, to purchase such Participation Rights Holder’s Pro Rata Share (as defined below) of all (or any part) of any New Securities (as defined in Section 3.3) that the Company may from time to time issue after the date of this Agreement (the “Right of Participation”).

 

3.2                                 Pro Rata Share. A Participation Rights Holder’s “Pro Rata Share” for purposes of the Right of Participation is the ratio of (a) the number of Common Shares (calculated on a fully-diluted and as-converted basis) then held by such Participation Rights Holder to (b) the total number of Common Shares (calculated on a fully-diluted and as-converted basis) then held by all Participation Rights Holders immediately prior to the issuance of New Securities giving rise to the Right of Participation.

 

3.3                                 New Securities. “New Securities” shall mean any class of shares or securities of the Company, including but not limited to the Preferred Shares, Common Shares or other shares of the Company, whether now authorized or not, and rights, options or warrants to purchase such Preferred Shares, Common Shares and securities of any type whatsoever that are, or may become, convertible or exchangeable into the Preferred Shares, Common Shares or other shares, without regard to the differences in voting rights; provided, however, that the term “New Securities” shall not include (the issuances pursuant to the subsections below collectively referred to as the “Permitted Issuances”):

 

25

 

(i)                                      any of the Common Shares, options or warrants issued to employees, officers, directors, contractors, advisors or consultants of the Company for up to 26,822,828 Common Shares pursuant to the Company’s 2010 share incentive plan (the “ESOP”) approved by at least four of the five members of the Board;

 

(ii)                                   any securities issued in connection with any share split, share dividend, subdivision, combination, reclassification or other similar event in which all Participation Rights Holders are entitled to participate on a pro rata basis, as approved by the Board;

 

(iii)                                any securities issued pursuant to any public offering (including, without limitation, a Qualified Public Offering);

 

(iv)                               any securities issued pursuant to the acquisition of another corporation or entity by the Company by consolidation, merger, purchase of assets, or other reorganization in which the Company acquires, in a single transaction or series of related transactions, all or substantially all assets of such other corporation or entity, or fifty percent (50%) or more of the equity ownership or voting power of such other corporation or entity;

 

(v)                                 any Conversion Shares;

 

(vi)                               any securities issued upon the exercise or conversion of any debenture, warrant, option, or other convertible securities outstanding prior to the issuance of the Series C Shares;

 

(vii)                            any securities issued in connection with a strategic partnership or joint venture entered into by the Company, which shall not be a private equity, venture capital or other similar financing and shall be approved by the Board (including at least the affirmative vote of the Series B Director, Series A-1 Director and Series A Director); and

 

(viii)                         any equity or convertible debt securities issued at a per share purchase or with a conversion price, as the case may be, equal to or greater than the per share purchase price for Series C Shares set forth in the Series C Subscription Agreement (adjusted for share splits, share dividends, combinations and the like).

 

3.4                                Procedures.

 

(a)                                   First Participate Notice. In the event that the Company proposes to undertake an issuance of New Securities (in a single transaction or a series of related transactions), it shall give to each Participation Rights Holder written notice of its intention to issue New Securities (the “First Participation Notice”), describing the amount and type of New Securities, the price and the general terms upon which the Company proposes to issue such New Securities. Each

 

26

 

Participation Rights Holder shall have fourteen (14) Business Days from the date of receipt of any such First Participation Notice to agree in writing to purchase such Participation Rights Holder’s Pro Rata Share of such New Securities for the price and upon the terms and conditions specified in the First Participation Notice by giving written notice to the Company and stating therein the quantity of New Securities to be purchased (not to exceed such Participation Rights Holder’s Pro Rata Share).  If any Participation Rights Holder fails to so agree in writing within such fourteen (14) Business Day period, then such Participation Rights Holder shall be deemed to have forfeited the right hereunder to purchase that part of its Pro Rata Share of such New Securities that it did not agree to purchase.

 

(b)                                  Second Participation Notice; Oversubscription. If any Participation Rights Holder fails or declines to exercise its Right of Participation in accordance with subsection (a) above, the Company shall promptly give notice (the “Second Participation Notice”) to other Participation Rights Holders who exercised their Right of Participation (the “Right Participants”) in accordance with subsection (a) above. Each Right Participant shall have five (5) Business Days from the date of receipt of the Second Participation Notice (the “Second Participation Period”) to notify the Company of its desire to purchase more than its Pro Rata Share of the New Securities, stating the number of the additional New Securities it proposes to buy (the “Additional Number”). Such notice may be made by telephone if confirmed in writing within two (2) Business Days.  If, as a result thereof, such oversubscription exceeds the total number of the remaining New Securities available for purchase, each oversubscribing Right Participant will be cut back by the Company with respect to its oversubscription to that number of remaining New Securities equal to the lesser of (x) the Additional Number and (y) the product obtained by multiplying (i) the number of the remaining New Securities available for subscription by (ii) a fraction, the numerator of which is the number of Common Shares (calculated on a fully-diluted and as-converted basis) held by such oversubscribing Right Participant and the denominator of which is the total number of Common Shares (calculated on a fully-diluted and as-converted basis) held by all the oversubscribing Right Participants.  Each Right Participant shall be obligated to buy such number of New Securities as determined by the Company pursuant to this Section 3.4(b) and the Company shall so notify the Right Participants within fourteen (14) Business Days following the date of the Second Participation Notice.

 

(c)                                   Failure to Exercise.  Upon the expiration of the Second Participation Period and to the extent that not all New Securities have been subscribed for by the Participation Rights Holders, or in the event no Participation Rights Holder exercises the Right of Participation within fourteen (14) days following the issuance of the First Participation Notice, the Company shall have 60 days thereafter to sell the New Securities described in the First Participation Notice (the portion to which the Right of Participation hereunder were not exercised) at the same or higher price and upon non-price terms not materially more favorable to the purchasers thereof than specified in the First Participation Notice.  In the event that the Company has not issued

 

27

 

and sold such New Securities within such 60 day period, then the Company shall not thereafter issue or sell any New Securities without again first offering such New Securities to the Participation Rights Holders pursuant to this Section 3.

 

3.5                                Termination. The Right of Participation for each Participation Rights Holder shall not terminate so long as any Investors and its Affiliates collectively hold any Series A-1 Shares, Series A Shares, Series B Shares, Series C Shares or Common Shares; provided, however, that the Right of Participation shall terminate upon the earlier of: the closing of a Qualified Public Offering, a Liquidation Event or a Deemed Liquidation Event, or a Trade Sale.

 

4.                                     TRANSFER RESTRICTIONS.

 

4.1                                 Certain Definitions. For purposes of this Section 4, “Common Shares” means (i) the Company’s outstanding Common Shares, (ii) the Common Shares issuable upon exercise of outstanding options or warrants and (iii) the Common Shares issuable upon conversion of any outstanding convertible securities other than Conversion Shares; “Preferred Holder” means an Investor and its permitted assignees to whom its rights under this Section 4 have been duly assigned in accordance with this Agreement; “Common Holders” means the holders of any Common Shares; and “Restricted Shares” means any of the Company’s securities including, without limitation, the Common Shares or securities convertible into or exercisable for Common Shares now owned or subsequently acquired by any Founder, any employee.

 

4.2                                 Restriction on Sale.  During the Restricted Period (as defined below), each holder of any class or series of Restricted Shares (such holder for the purposes of this Section 4, the “Shareholder”) agrees not to, directly or indirectly, transfer, sell or pledge or otherwise dispose of or permit the transfer, sale, pledge, or other disposition of, any Restricted Shares except in compliance with this Section 4.  In the event of an involuntary transfer of Restricted Shares during the Restricted Period pursuant to divorce, legal separation, bankruptcy or insolvency, such involuntary transfer shall be conducted in accordance with the applicable provisions of this Section 4.  Each Shareholder (if applicable) shall procure that restrictions set forth in this Section 4 shall not be avoided by the direct or indirect transfer, sale, pledge, or other disposition of any shares (or other interest) in such Shareholder or of any other entity having control over such Shareholder.

 

4.3                                Right of First Refusal and Right of Co-Sale.

 

(a)                                   Transfer Notice.  If (i) a Shareholder proposes to, directly or indirectly, transfer, sell or pledge or otherwise dispose of or permit the transfer, sale, pledge, or other disposition of, any Restricted Shares held by him to one or more third parties or (ii) at any time any Restricted Shares held by such Shareholder are transferred involuntarily pursuant to divorce, legal separation, bankruptcy or other proceedings, death or any other involuntary transfer (each such

 

28

 

disposition referenced in this Section 4, a “Transfer”), then such Shareholder (or, upon an involuntary transfer, the person to whom the Offered Shares (as defined below) are or were to be transferred (such Shareholder, or such person, a “Selling Shareholder”) shall give the Company and each Preferred Holder written notice of such Selling Shareholder’s intention to make such Transfer (the “Transfer Notice”), which Transfer Notice shall include (i) a description of the Restricted Shares to be transferred (the “Offered Shares”), (ii) the identity of the prospective transferee(s) and (iii) the consideration and the material terms and conditions upon which the proposed Transfer is to be made. The Transfer Notice shall certify that such Selling Shareholder has received a firm offer from the prospective transferee(s) and in good faith believes a binding agreement for the Transfer is obtainable on the terms set forth in the Transfer Notice.  The Transfer Notice shall also include a copy of any written proposal, term sheet or letter of intent or other agreement relating to the proposed Transfer.  The Transfer Notice shall constitute an irrevocable offer by the Selling Shareholder to sell the Offered Shares to the other Shareholders in the following order: firstly, to each holder of the Series C Shares (the “Series C Holder”) and each holder of the Series B Shares (the “Series B Holder”) on a pro rata and as converted basis, and for any remaining Offered Shares not purchased by the Series C Holders and the Series B Holders, to the holders of the Series A-1 Shares (the “Series A-1 Holder”), and for any remaining Offered Shares not purchased by the Series A-1 Holders, to the holders of the Series A Shares (the “Series A Holder”), and for any remaining Offered Shares not purchased by the Series A Holders, to the Common Holders.

 

(b)                                 Option of Series C Holders and Series B Holders to Purchase.

 

(i)                                      Each of the Series B Holders and the Series C Holders who notifies such Selling Shareholder in writing within ten (10) Business Days after receipt of the Transfer Notice (“Series B/C Purchase Period”) referred to in Section 4.3(a) (each a “Purchasing B/C Holder”) shall have the right, exercisable upon such written notice to the Selling Shareholder (the “Purchase and Co-Sale Notice”), to purchase up to its pro rata share of the Offered Shares plus up to its pro rata share of any Offered Shares not purchased by any other Series B Holder or Series C Holder (the “Remaining Shares”) on the same terms and conditions as set forth in the Transfer Notice, subject to Section 4.3(f)(i) below.  The Purchase and Co-Sale Notice shall state (A) whether the Series C Holder or the Series B Holder desires to purchase up to its pro rata share of the Offered Shares, (B) whether the Series C Holder or the Series B Holder desires to purchase the maximum amount of its pro rata share of the Remaining Shares, and (C) whether the Series C Holder or the Series B Holder elects not to purchase any of the Offered Shares but wishes to sell a portion of the securities held by such Series C Holder or Series B Holder pursuant to Section 4.3(g) of this Agreement and the number of securities to be sold (subject to Section 4.3(g)(ii)).  A Series C Holder or Series B Holder has option either to purchase or to sell under this Section 4 and such right shall not be construed as an option to both purchase and sell with respect to the same Transfer.  A Series C Holder or Series B Holder who either does

 

29

 

not deliver a Purchase and Co-Sale Notice or indicates in the Purchase and Co-Sale Notice that such Series C Holder or Series B Holder elected not to purchase any of the Offered Shares shall be referred to herein as a “Non-Purchasing Holder.”

 

(ii)                                   Each Purchasing B/C Holder who sets forth in the Purchase and Co-Sale Notice a desire to purchase the maximum amount of Offered Shares available shall be entitled to purchase its pro rata share of the Remaining Shares.

 

(iii)                                Each Purchasing B/C Holder’s pro rata share shall be equal to a fraction, the numerator of which is the number of Conversion Shares held by such Purchasing B/C Holder and the denominator of which is the total number of Conversion Shares held by all Series B Holders and all Series C Holders calculated immediately prior to the time of the purchase hereunder from the Selling Shareholder, provided, however, that with respect to the Remaining Shares, the denominator shall be total number of Conversion Shares held by the Purchasing B/C Holders that are purchasing the Remaining Shares.  Upon expiration of the Series B/C Purchase Period, the Selling Shareholder will provide notice to all Series B Holders and all Series C Holders as to whether or not the Right of First Refusal has been exercised by the Series B Holders and the Series C Holders (“Series B/C Expiration Notice”).

 

(c)                                  Series A-1 Holders’ Option to Purchase.

 

(i)                                      Series A-1 Transfer Notice. If any of the Offered Shares proposed in the Transfer Notice to be transferred are not purchased by the Series B Holders and the Series C Holders (“Series A-1 Remaining Offered Shares”), then after the issue of the Series B/C Expiration Notice and subject to the co-sale rights set forth in this Agreement, the Selling Shareholder shall give the Series A-1 Holder an additional Transfer Notice (“Series A-1 Transfer Notice”) which shall include an offer to sell the Remaining Offered Shares and all of the information and certifications required in a Transfer Notice.

 

(ii)                                   Each Series A-1 Holder who notifies such Selling Shareholder in writing within ten (10) Business Days after receipt of the Series A-1 Transfer Notice (“Series A-1 Purchase Period”) referred to above (each a “Purchasing A-1 Holder”) shall have the right, exercisable upon such written notice to the Selling Shareholder in a Purchase and Co-Sale Notice, to purchase up to its pro rata share of the Offered Shares plus up to its pro rata share of any Offered Shares not purchased by any other Series A-1 Holder (the “Remaining A-1 Shares”) on the same terms and conditions as set forth in the Series A-1 Transfer Notice, subject to Section 4.3(f)(i) below.  The Purchase and Co-Sale Notice shall state (A) whether the Series A-1 Holder desires to purchase up to its pro rata share of the Offered Shares, (B) whether the Series A-1 Holder desires to purchase the maximum amount of its pro rata share of the Remaining Shares, and (C) whether the Series A-1 Holder elects not to purchase any of the Offered Shares but

 

30

 

wishes to sell a portion of the securities held by such Series A-1 Holder pursuant to Section 4.3(g) of this Agreement and the number of securities to be sold (subject to Section 4.3(g)(ii)).  A Series A-1 Holder has option either to purchase or to sell under this Section 4 and such right shall not be construed as an option to both purchase and sell with respect to the same Transfer.

 

(iii)                                Each Purchasing A-1 Holder who sets forth in the Purchase and Co-Sale Notice a desire to purchase the maximum amount of Offered Shares available shall be entitled to purchase its pro rata share of the Remaining A-1 Shares.

 

(iv)                               Each Purchasing A-1 Holder’s pro rata share shall be equal to a fraction, the numerator of which is the number of Conversion Shares held by such Purchasing A-1 Holder and the denominator of which is the total number of Conversion Shares held by all Series A-1 Holders calculated immediately prior to the time of the purchase hereunder from the Selling Shareholder, provided, however, that with respect to the Remaining Shares, the denominator shall be total number of Conversion Shares held by the Purchasing A-1 Holders that are purchasing the Remaining Shares.  Upon expiration of the Series A-1 Purchase Period, the Selling Shareholder will provide notice to all Series A-1 Holders as to whether or not the Right of First Refusal has been exercised by the Series A-1 Holders (“Series A-1 Expiration Notice”).

 

(d)                                 Series A Holders’ Option to Purchase.

 

(i)                                      Series A Transfer Notice. If any of the Offered Shares proposed in the Transfer Notice to be transferred are not purchased by the Series A-1 Holders (“Remaining Offered Shares”), then after the issue of the Series A-1 Expiration Notice and subject to the co-sale rights set forth in this Agreement, the Selling Shareholder shall give each holder of Series A Shares (“Series A Holders”) an additional Transfer Notice (“Series A Transfer Notice”) which shall include an offer to sell the Remaining Offered Shares and all of the information and certifications required in a Transfer Notice.

 

(ii)                                   Each Series A Holder who notifies such Selling Shareholder in writing within ten (10) Business Days after receipt of the Series A Transfer Notice (“Series A Purchase Period”) referred to above (each a “Purchasing A Holder”) shall have the right, exercisable upon such written notice to the Selling Shareholder in a Purchase and Co-Sale Notice, to purchase up to its pro rata share of the Offered Shares plus up to its pro rata share of any Offered Shares not purchased by any other Series A Holder (the “Remaining A Shares”) on the same terms and conditions as set forth in the Series A Transfer Notice, subject to Section 4.3(c)(i) below.  The Purchase and Co-Sale Notice shall state (A) whether the Series A Holder desires to purchase up to its pro rata share of the Offered Shares, (B) whether the Series A Holder desires to purchase the maximum amount of its pro rata share of the Remaining Shares, and (C) whether the Series A Holder elects not to purchase any of the Offered Shares but wishes to sell a portion

 

31

 

of the securities held by such Series A Holder pursuant to Section 4.3(g) of this Agreement and the number of securities to be sold (subject to Section 4.3(g)(ii)).  A Series A Holder has option either to purchase or to sell under this Section 4 and such right shall not be construed as an option to both purchase and sell with respect to the same Transfer.

 

(iii)           Each Purchasing A Holder who sets forth in the Purchase and Co-Sale Notice a desire to purchase the maximum amount of Offered Shares available shall be entitled to purchase its pro rata share of the Remaining A Shares.

 

(iv)           Each Purchasing A Holder’s pro rata share shall be equal to a fraction, the numerator of which is the number of Conversion Shares held by such Purchasing A Holder and the denominator of which is the total number of Conversion Shares held by all Series A Holders calculated immediately prior to the time of the purchase hereunder from the Selling Shareholder, provided, however, that with respect to the Remaining Shares, the denominator shall be total  number of Conversion Shares held by the Purchasing A Holders that are purchasing the Remaining Shares.  Upon expiration of the Series A Purchase Period, the Selling Shareholder will provide notice to all Series A Holders as to whether or not the Right of First Refusal has been exercised by the Series A Holders (“Series A Expiration Notice”).

 

(e)                                  Common Holders’ Option to Purchase.

 

(i)             Common Transfer Notice. If any of the Offered Shares proposed in the Transfer Notice to be transferred are not purchased by the Series A Holders (“Remaining Offered Shares”), then after the issue of the Series A Expiration Notice and subject to the co-sale rights set forth in this Agreement, the Selling Shareholder shall give each Common Holder an additional Transfer Notice (“Common Transfer Notice”) which shall include an offer to sell the Remaining Offered Shares and all of the information and certifications required in a Transfer Notice.

 

(ii)            Each Common Holder who notifies such Selling Shareholder in writing within ten (10) Business Days after receipt of the Common Transfer Notice (“Common Purchase Period”) referred to above (each a “Purchasing Common Holder”) shall have the right, exercisable upon such written notice to the Selling Shareholder in a Purchase and Co-Sale Notice, to purchase up to its pro rata share of the Offered Shares plus up to its pro rata share of any Offered Shares not purchased by any other Common Holder (the “Remaining Common Shares”) on the same terms and conditions as set forth in the Common Transfer Notice, subject to Section 4.3(c)(i) below.  The Purchase and Co-Sale Notice shall state (A) whether the Common Holder desires to purchase up to its pro rata share of the Offered Shares, (B) whether the Common Holder desires to purchase the maximum amount of its pro rata share of the Remaining Shares, and (C) whether the Common Holder elects not to purchase any of the

 

32

 

Offered Shares but wishes to sell a portion of the securities held by such Common Holder pursuant to Section 4.3(g) of this Agreement and the number of securities to be sold (subject to Section 4.3(g)(ii)).  A Common Holder has option either to purchase or to sell under this Section 4 and such right shall not be construed as an option to both purchase and sell with respect to the same Transfer.

 

(iii)           Each Purchasing Common Holder who sets forth in the Purchase and Co-Sale Notice a desire to purchase the maximum amount of Offered Shares available shall be entitled to purchase its pro rata share of the Remaining Common Shares.

 

(iv)           Each Purchasing Common Holder’s pro rata share shall be equal to a fraction, the numerator of which is the number of Conversion Shares held by such Purchasing Common Holder and the denominator of which is the total number of Conversion Shares held by all Common Holders calculated immediately prior to the time of the purchase hereunder from the Selling Shareholder, provided, however, that with respect to the Remaining Shares, the denominator shall be total number of Conversion Shares held by the Purchasing Common Holders  that are purchasing the Remaining Shares.  Upon expiration of the Common Purchase Period, the Selling Shareholder will provide notice to all Common Holders as to whether or not the Right of First Refusal has been exercised by the Common Holders (“Common Expiration Notice”).

 

(f)                                    Involuntary Transfers; Non-Cash Consideration.

 

(i)             In the event that the Transfer in question is by operation of law or another involuntary Transfer (including a Transfer incident to death, divorce, legal separation or bankruptcy), the price per share shall be the greater of (A) the original purchase price paid by Selling Shareholder for such Offered Shares (adjusted for share splits, share dividends, combinations and the like) or (B) the fair market value of such Offered Shares, which shall be a price set by the Board that will reflect the current value of the Offered Shares in terms of present earnings and future prospects of the Company, determined within thirty (30) days after receipt by the Shareholders of the Transfer Notice. In the event that the Selling Shareholder or the Selling Shareholder’s executor disagrees with such valuation as determined by the Board, the Selling Shareholder or the Selling Shareholder’s executor shall be entitled to have the valuation determined by an independent appraiser to be mutually agreed upon by the Purchasing Shareholders and the Selling Shareholder or the Selling Shareholder’s executor, the fees of which appraiser shall be borne equally by the Purchasing Shareholders and the Selling Shareholder or the Selling Shareholder’s estate.

 

(ii)            In the event the consideration for the Offered Shares specified in a Transfer Notice is payable in property other than cash and the Shareholders who wish to

 

33

 

purchase the Offered Shares under Section 4.3(b) (acting together), as the case may be, cannot agree on the cash value of such property within ten (10) days after such Shareholders’ receipt of the Transfer Notice, as the case may be, the value of such property shall be determined by an appraiser of recognized standing selected jointly by the Selling Shareholder and the Shareholders (acting together), as the case may be.  If they cannot agree on an appraiser within twenty (20) days after receipt of the Transfer Notice by such Preferred Holders, as the case may be, within a further five(5)-day period, the Selling Shareholder and such Shareholders (acting together), as the case may be, shall each select an appraiser of recognized standing and the two appraisers shall designate a third appraiser of recognized standing to determine the value of such property.  The value of such property shall be determined by the appraiser selected pursuant to this Section 4.3(f)(ii) within one (1) month from its appointment, and such determination shall be final and binding on the Selling Shareholder and such Shareholders, as the case may be.  The cost of such appraisal shall be shared equally by the Selling Shareholder, on the one hand, and such Shareholders, as the case may be, on the other hand (each Shareholder shall pay its pro rata portion of such costs based on the number of Offered Shares acquired by each such Shareholder).  If the ten (10) day period as specified in Section 4.3 has expired but for the determination of the value of the consideration for the Offered Shares offered by the Selling Shareholder, then such ten (10) day period shall be extended to the fifth  Business Day after such valuation shall have been determined to be final and binding pursuant to this Section 4.3(f)(ii).

 

(g)                                 Right of Co-Sale.

 

(i)             Following the expiration of the right of first refusal and purchase rights described in Sections 4.3(b), (c), (d) and (e), each Preferred Holder who previously notified the Selling Shareholder in the Purchase and Co-Sale Notice of such Preferred Holder’s desire to sell a portion of its shares with the Selling Shareholder (such Preferred Holder, a “Co-Sale Participant”) shall have the right to participate in the sale of any Offered Shares that were not purchased by the Shareholders pursuant to Sections 4.3(b), (c), (d) and (e), on the same terms and conditions as specified in the Transfer Notice; provided, however, that (a) holders of Series A-1 Shares shall not be entitled to participate under this Section 4.3(g)(i) and shall not be deemed as a Co-Sale Participant as provided in Section 4.3(g)(ii) unless all Co-Sale Participants holding Series B Shares and Series C Shares have first exercised or declined to exercise their right of co-sale under this Section 4.3(g); (b) holders of Series A Shares shall not be entitled to participate under this Section 4.3(g)(i) and shall not be deemed as a Co-Sale Participant as provided in Section 4.3(g)(ii) unless all Co-Sale Participants holding Series A-1 Shares have first exercised or declined to exercise their right of co-sale under this Section 4.3(g); and (c) no Preferred Holders shall be entitled under this Section 4.3(g) to participate in Transfers of Restricted Shares by a Selling Shareholder incident to divorce, legal separation, bankruptcy or other proceedings, or death or in any other involuntary Transfers of Restricted Shares by a Selling Shareholder.  To the extent one or more Preferred Holders exercise such right of co-sale

 

34

 

in accordance with the terms and conditions set forth below, the number of Restricted Shares that the Selling Shareholder may sell in the Transfer shall be correspondingly reduced. Shareholders shall not have any right of first refusal to purchase the Shares to be sold by the Co-Sale Participants pursuant to this Section 4.3(g).

 

(ii)            Each Co-Sale Participant may sell all or any part of that number of Conversion Shares equal to the product obtained by multiplying (A) the Offered Shares, less (x) any Offered Shares purchased by the Purchasing Holders, (y) when holders of Series A-1 Shares shall be deemed Co-Sale Participants, any Conversion Shares holders of Series B Shares and Series C Shares shall have elected to co-sell under this Section 4.3(g), and (z) when holders of Series A Shares shall be deemed Co-Sale Participants, any Conversion Shares holders of Series A-1 Shares, Series B Shares and Series C Shares shall have elected to co-sell under this Section 4.3(g), by (B) a fraction, the numerator of which shall be the number of Co-Sale Shares owned by such Co-Sale Participant and the denominator of which shall be the total number of Co-Sale Shares held by all Co-Sale Participants and the Common Shares (assuming full conversion of outstanding Preferred Shares) held by the Selling Shareholder, calculated immediately prior to the time of the Transfer.  For the purpose of this Section 4.3(g)(ii), “Co-Sale Shares” means (A) any Common  Shares issued or issuable upon conversion of the Series B or Series C Shares if the Co-Sale Participants are the holders of Series B or Series C Shares, (B) any Common Shares issued or issuable upon conversion of the Series A-1 Shares if the Co-Sale Participants are the holders of Series A-1 Shares, and (C) any Common Shares issued or issuable upon conversion of the Series A Shares if the Co-Sale Participants are the holders of Series A Shares.

 

(h)           Transferred Shares. Each Co-Sale Participant shall effect its participation in the sale by promptly delivering to the Selling Shareholder for transfer to the prospective purchaser a duly executed instrument of transfer and one or more certificates, which represent:

 

(i).            the series and number of securities of the Company which such Co-Sale Participant elects to sell;

 

(ii).           that number of Common Shares, or that number of Preferred Shares which are at such time convertible into the number of Common Shares, which such Co-Sale Participant elects to sell; provided, however, that if the prospective third-party purchaser objects to the delivery of Preferred Shares in lieu of Common Shares, such Co-Sale Participant shall first convert such Preferred Shares into Common Shares and transfer the Common Shares as provided in this Section 4.3(h).  The Company agrees to make any such conversion concurrent with the actual transfer of such shares to the purchaser and contingent upon such Transfer; or

 

(iii).          a combination of the above.

 

35

 

(i)             Payment. The share certificate or certificates that the Co-Sale Participant delivers to such Selling Shareholder pursuant to Section 4.3(h) shall be returned to the Company for cancellation in consummation of the sale of the Offered Shares pursuant to the terms and conditions specified in the Transfer Notice, and such Selling Shareholder shall concurrently therewith remit to such Co-Sale Participant that portion of the sale proceeds to which such Co-Sale Participant is entitled by reason of its participation in such sale.  To the extent that any prospective purchaser or purchasers prohibit(s) such assignment or otherwise refuse(s) to purchase shares or other securities from a Co-Sale Participant exercising its rights of co-sale hereunder, such Selling Shareholder shall not sell to such prospective purchaser or purchasers any Restricted Shares unless and until, simultaneously with such sale, such Selling Shareholder shall purchase such shares or other securities from such Co-Sale Participant for the same consideration and on the same terms and conditions as the proposed Transfer described in the Transfer Notice.  The Company shall, upon receiving the relevant instruments of transfer duly executed by the Co-Sale Participant and the surrendering by the Co-Sale Participant or the Selling Shareholder of the certificates for the Preferred Shares or Common Shares being transferred as provided above, make proper entries in the register of members of the Company and cancel the surrendered certificates and issue any new certificates in the name of the prospective purchaser or the Selling Shareholder, as the case may be,  as necessary to consummate the transactions in connection with the exercise by the Co-Sale Participant of their co-sale rights under this Section 4.3.

 

4.4           Non-Exercise of Rights. To the extent that the Shareholders have not exercised their rights to purchase all of a Selling Shareholder’s Offered Shares, such Selling Shareholder together with any Co-Sale Participant shall have a period of sixty (60) days from the expiration of such rights in which to sell any remaining Offered Shares, upon terms and conditions (including the purchase price) no more favorable to the purchaser than those specified in the Transfer Notice, to the third-party transferee(s) identified in the Transfer Notice. The third-party transferee(s) shall, as a condition to the effectiveness of Transfer of the Offered Shares, furnish the Company and the Shareholders with a written agreement to be bound by and comply with this Agreement, including without limitation all provisions of this Section 4, as if such transferee(s) were a Selling Shareholder hereunder, as well as the terms of the agreement pursuant to which such Restricted Shares were issued. In the event a Selling Shareholder does not consummate the sale or disposition of the Offered Shares within the sixty (60)-day period from the expiration of these rights, the Shareholders’ first refusal rights hereunder shall continue to be applicable to any subsequent disposition of the Restricted Shares by such Selling Shareholder. Furthermore, the exercise or non-exercise by the Shareholders to purchase Restricted Shares from such Selling Shareholder shall not adversely affect the Shareholders’ rights to make subsequent purchases from any Selling Shareholder of Restricted Shares.  Any proposed Transfer on terms and conditions different from those described in the Transfer Notice, as well as any subsequent proposed Transfer of any of the Selling Shareholders’ Restricted

 

36

 

Shares shall again be subject to the right of the Shareholders under this Section 4 and shall require compliance by the relevant Selling Shareholder with the procedures described in this Section 4.

 

4.5           Exempt Transfers. Notwithstanding anything to the contrary contained herein, the right of first refusal and co-sale rights of the Preferred Holders shall not apply to (a) any Transfer or Transfers made pursuant to Section 5 below, (b) any repurchase of Shares by the Company pursuant to any right of repurchase in the event of a termination of employment or consulting relationship or pursuant to the terms of the ESOP, (c) any transfer to (x) an Affiliate of the Selling Shareholder or (y) wholly-owned subsidiary of the Selling Shareholder which is directly or indirectly controlled by the Selling Shareholder, provided that the transferee so transferred shall not be a Competitor of any of the Group Companies, (d) in the case of a Transferor that is a natural person, transfers by the Transferor upon his or her death by will or intestacy to his or her siblings, children, grandchildren, spouse or any other relatives approved by unanimous consent of the Board, or any transfer to the parents, children or spouse, or to trusts for the exclusive benefit of such persons, of any Common Holder for bona fide tax and/or estate planning purposes, (e) any transfer by a Founder to any person (either individual, firm, corporation, partnership, trust, incorporated or unincorporated association, joint venture, joint stock company, limited liability company, or other entity of any kind) not exceeding, when aggregated with all of the Shares  previously transferred by such Founder, ten per cent (10%) of all Shares held by him at the time of transfer, (f) without limiting the foregoing subsection (a), any transfer by Fidelity to any Fidelity Persons or charitable organization and (g) the Company’s Transfer, repurchase and cancellation of up to 56,067,952 Common Shares that the Company held in its own name as of March 1, 2011 (the “Treasury Shares”), provided that the transferee so transferred shall not be a Competitor of any of the Group Companies (each transferee pursuant to the foregoing subsections (c), (d), (e) and (f), a “Permitted Transferee”); provided that adequate documentation therefor is provided to the Investors to their satisfaction and that any such Permitted Transferee agrees in writing to be bound by this Agreement in place of the relevant transferor; provided, further, that such transferor shall remain liable for any breach by such Permitted Transferee of any provision hereunder. Each Shareholder (other than the Selling Shareholder) hereby waives its right of first refusal and right of co-sale under this Section 4 in respect of such transfer of Restricted Shares to any Permitted Transferee. For the purpose of this Agreement, “Fidelity Persons” means (1) Fidelity International Limited (“FIL”), a company incorporated in Bermuda, and any subsidiary undertaking of FIL from time to time (FIL and its subsidiary undertakings being the “FIL Group”); (2) FMR Corp. (“FMR”), a Delaware corporation, and any subsidiary undertaking of FMR from time to time (FMR and its subsidiary undertakings being the “FMR Group”); (3) any director, officer, employee or shareholder of the FIL Group and/or the FMR Group or members of his family and any company, trust, partnership or other entity (“Fidelity Entities”) formed for his or any of their benefit from time to time (any or all of such individuals and Fidelity Entities being the “Closely Related Shareholders”); (4)

 

37

 

any Fidelity Entity controlled by Closely Related Shareholders where “control” shall mean the power to direct the management and policies or appoint or remove members of the board of directors or other governing body of the Fidelity Entity, directly or indirectly, whether through the ownership of voting securities, contract or otherwise, and “controlled” shall be construed accordingly; and (5) any affiliate of any member of the FIL Group and/or the FMR Group (where “affiliate” means any Fidelity Entity controlled by any combination of any Closely Related Shareholders and any member of the FIL Group and/or the FMR Group, and includes the officers, partners and directors of any affiliate).  For the purpose of this Agreement, “Affiliate” means (a) in relation to any individual, the immediate family of such individual or any entity controlled by the individual (and in the case of the Founder, whether by himself or together with other Founders), and (b) in relation to any legal person, any other person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with the specified person.  For purposes of this definition and notwithstanding the definition with respect to Fidelity Entities in clause (3) above, a person shall be deemed to be “controlled by” another person if the other possesses, directly or indirectly, power either (i) to vote fifty percent (50%) or more of the securities having voting power for the election of directors of such person, or (ii) to direct or cause the direction of the management and policies of such person whether by contract or otherwise.

 

4.6                               Prohibited Transfers.

 

(a)            In the event a Selling Shareholder should sell any Restricted Shares in contravention of the transfer restrictions in this Section 4 or such Selling Shareholder fails to procure that its transferee (whether a third party transferee, an affiliate or otherwise) agree in writing to be bound by and comply with the rights and obligations of such Selling Shareholder under this Agreement, including, without limitation, all provisions of this Section 4 (each, a “Prohibited Transfer”), the Preferred Holders, in addition to such other remedies as may be available at law, in equity or hereunder, shall have the put option provided below and such Selling Shareholder shall be bound by the applicable provisions of such option.

 

(b)           In the event of a Prohibited Transfer, each Preferred Holder shall have the right to sell to such Selling Shareholder the type and number of shares of Common Shares, Conversion Shares or Preferred Shares equal to the number of shares each Preferred Holder would have been entitled to transfer to the third-party transferee(s) under Section 4.3(g) hereof had the Prohibited Transfer been effected pursuant to and in compliance with the terms hereof (assuming the Company had not exercised its right of first refusal and no Preferred Holder had elected to become Purchasing Holders).  Such sale shall be made on the following terms and conditions:

 

(i)             The price per share at which the shares are to be sold to such Selling Shareholder shall be equal to the price per share paid by the third-party transferee(s) to such

 

38

 

Selling Shareholder in the Prohibited Transfer.  The Selling Shareholder shall also reimburse each Preferred Holder for any and all fees and expenses, including legal fees and expenses, incurred pursuant to the exercise or the attempted exercise of the Preferred Holder’s rights under this Section 4.

 

(ii)            Within thirty (30) days after the later of the dates on which the Preferred Holder (A) received notice of the Prohibited Transfer or (B) otherwise became aware of the Prohibited Transfer, each Preferred Holder shall, if exercising the option created hereby, deliver to such Selling Shareholder a duly executed instrument of transfer and the certificate or certificates representing shares to be sold.

 

(iii)           The Selling Shareholder shall, upon receipt of the certificate or certificates for the shares to be sold by a Preferred Holder, pursuant to this Section 4.6, pay the aggregate purchase price therefor and the amount of reimbursable fees and expenses, as specified in Section 4.6(b)(i), in cash or by other means acceptable to the Preferred Holder.

 

(iv)           Notwithstanding the foregoing, any attempt by such Selling Shareholder to transfer Restricted Shares in violation of this Section 4 hereof shall be null and void and the Company agrees it will not effect such a Transfer nor will it treat any alleged transferee(s) as the holder of such shares without the written consent of the holders of a majority of the then outstanding Series A Shares, the holders of a majority of the then outstanding Series B Shares and  the holders of a majority of the then outstanding Series C Shares, each voting together as a separate class.

 

4.7                                Term. The provisions under this Section 4 shall terminate upon the earlier to occur of:

 

(a)                                  the closing of a Qualified Public Offering; and

 

(b)                                 a Trade Sale (as defined below).

 

The period from the date hereof to such termination date is defined as the “Restricted Period”.

 

4.8                                Legend.

 

(a)            Each certificate representing the Restricted Shares shall be endorsed with the following legend:

 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES

 

39

 

LAWS OF ANY STATE OF THE UNITED STATES OR ANY FOREIGN JURISDICTION. THE SECURITIES MAY NOT BE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE AND FOREIGN SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS.

 

THE SALE, ASSIGNMENT, HYPOTHECATION, PLEDGE, ENCUMBRANCE OR OTHER DISPOSITION (EACH A “TRANSFER”) AND VOTING OF ANY OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE RESTRICTED BY THE TERMS OF THE FOURTH AMENDED AND RESTATED SHAREHOLDERS AGREEMENT, DATED April       , 2011 BY AND AMONG THE COMPANY, ITS SUBSIDIARIES AND THE SHAREHOLDERS NAMED THEREIN, A COPY OF WHICH MAY BE INSPECTED AT THE COMPANY’S PRINCIPAL OFFICE. THE COMPANY WILL NOT REGISTER THE TRANSFER OF SUCH SECURITIES ON THE BOOKS OF THE COMPANY UNLESS AND  UNTIL THE TRANSFER HAS BEEN MADE IN COMPLIANCE WITH THE TERMS OF SUCH SHAREHOLDERS AGREEMENT.”

 

(b)            Each party agrees that the Company may instruct its transfer agent to impose transfer restrictions on the shares represented by certificates bearing the legend referred to in Section 4.8(a) above to enforce the provisions of this Agreement and the Company agrees to promptly do so.  The legend shall be removed upon termination of the provisions of this Section 4.

 

4.9           Restriction on Indirect Transfers.  Notwithstanding anything to the contrary contained herein, without the prior written approval of the holders of a majority of the then outstanding Preferred Shares, voting together as a single class on an as converted basis (the “Majority Preferred”):

 

(a)           None of the Company, the Founders and the Common Holders shall, nor shall any of them cause or permit any other person to, directly or indirectly, sell, assign, transfer, pledge, hypothecate, mortgage, encumber or otherwise dispose through one or a series of transactions any equity interest held or controlled by it/him in the PRC Subsidiary or any other Subsidiary to any person.  Any transfer in violation of this Section 4.9(a) shall be null and void and each of the Subsidiaries hereby agrees it will not effect such a transfer nor will it treat any alleged

 

40

 

transferee as the holder of such equity interest without the prior written approval of the Majority Preferred.

 

(b)           None of the Subsidiaries or the Founders shall, nor shall any Common Holder cause or permit any Subsidiary to issue to any person any equity securities of such Subsidiary, or any options or warrants for, or any other securities exchangeable for or convertible into, such equity securities of such Subsidiary.

 

5.                                     DRAG ALONG.

 

5.1           Drag-Along Rights.  Notwithstanding anything herein to the contrary, but subject to Section 5.6, if the holders of ninety percent (90%) or more of all voting power of the Company, voting together as a single class on an as converted basis (collectively, the “Drag-Along Shareholders”), approve a Transfer of all Shares held by them to a purchaser, or approve a proposed Trade Sale (each, a “Drag-Along Sale”), then, in any such event, upon written notice from such Drag-Along Shareholders requesting them to do so, each of the other shareholders of the Company (the “Dragged Shareholders”) shall (i) vote, or give its written consent with respect to, all Shares held by them in favor of such proposed Drag-Along Sale and in opposition of any proposal that could reasonably be expected to delay or impair the consummation of any such proposed Drag-Along Sale; (ii) transfer all of their Shares in such Drag-Along Sale to such purchaser; (iii) refrain from exercising any dissenters’ rights or rights of appraisal under applicable law at any time with respect to or in connection with such proposed Drag-Along Sale; and (iv) take all actions reasonably necessary to consummate the proposed Drag-Along Sale, including without  limitation amending the then existing Restated Articles. All proceeds derived from a Dragged-Along Sale shall be distributed among the holders of Preferred Shares and holders of Common Shares in accordance with the Restated Articles.  Notwithstanding any provision to the contrary, the share transfer restrictions of Section 4 of this Agreement shall not apply to any transfers made pursuant to this Section 5, provided that there shall be no Drag-Along Sale in the event that the Preferred Holders other than the Drag-Along Shareholders (the “Minority”) shall agree to purchase all Shares proposed to be sold on the same terms as the proposed Drag-Along Sale within 10 Business Days after receipt by the Minority of the Drag Along Notice (as defined below) (the “Minority Purchase Right”), in which case all proceeds derived from such sale shall be distributed among the holders of Preferred Shares (other than the Minority exercising the Minority Purchase Right) and holders of Common Shares in accordance with the Restated Articles. The Minority Purchase Right shall be exercised by the Minority in the manner set forth in Sections 5.6 and 5.7 below.

 

41

 

5.2                                Representation and Undertaking.

 

(a)            Any such sale or disposition by the Dragged Shareholders shall be on the terms and conditions as the proposed Drag-Along Sale by the Drag-Along Shareholders.  Subject to Section 5.3, such Dragged Shareholders shall be required to make customary and usual representations and warranties in connection with the Drag-Along Sale, including, without limitation, as to their ownership and authority to sell, free of all liens, claims and encumbrances of any kind  other than customary permitted liens, the Shares proposed to be transferred or sold by such persons or entities; and such sale or transfer not constituting a violation or breach of or default under (with or without the giving of notice or the lapse of time or both) any law or regulation applicable to such Dragged Shareholders or any material contract to which such Dragged Shareholders is a party or by which they are bound, and shall, severally and not jointly, indemnify and hold harmless the purchasers against all costs, damages, expenses, losses, judgments or liabilities for any breach or alleged breach of any representation or warranty made by such Dragged Shareholders under the terms of the agreements relating to such Drag-Along Sale, which indemnification shall be limited, in the aggregate, to each such Dragged Shareholder’s pro rata share of the indemnification amount and in no event exceed the amount of consideration actually paid to such Dragged Shareholder in connection with such Drag-Along Sale.

 

(b)           Subject to Section 5.3 hereof, each of the Dragged Shareholders undertakes to obtain all consents, permits, approvals, orders, authorizations or registrations, qualifications, designations, declarations or filings with any governmental authority or any third party (the “Consents”), which are required to be obtained or made in connection with the Drag-Along Sale; provided, that such Consents should be obtained or made without significant expenses. Each of the Drag-Along Shareholders and the Dragged Shareholders further undertakes to pay its pro rata share of costs and expenses arising out of or in connection with the Drag-Along Sale.

 

5.3           Drag-Along Notice.  Prior to making any Drag-Along Sale in which the Drag-Along Shareholders wish to exercise their rights under this Section 5, the Drag-Along Shareholders shall provide the Company and the Dragged Shareholders with written notice (the “Drag-Along Notice”) not less than thirty (30) days prior to the proposed date of closing of the Drag-Along Sale (the “Drag-Along Sale Date”). The Drag-Along Notice shall set forth: (a) the name and address of the purchasers; (b) the proposed amount and form of consideration to be paid, and the terms and conditions of payment offered by each of the purchasers; (c) the Drag-Along Sale Date; (d) the number of shares held of record by the Drag-Along Shareholders on the date of the Drag-Along Notice which form the subject to be transferred, sold or otherwise disposed of by the Drag-Along Shareholders; and (e) the number of Shares of the Dragged Shareholders to be included in the Drag-Along Sale.  In the event that the Drag-Along Sale Date does not occur within ninety (90) days after the date of the Drag-Along Notice, the shareholders of the Company shall have no obligations to sell their Shares unless they receive a new Drag-Along Notice or otherwise agree with the purchaser(s) in writing.

 

42

 

5.4           Transfer Certificate.  On the Drag-Along Sale Date, each of Drag-Along Shareholders and the Dragged Shareholders shall each deliver or cause to be delivered an instrument of transfer and a certificate or certificates evidencing its Shares to be included in the Drag-Along Sale, duly endorsed for transfer with signatures guaranteed, to such third party purchasers in the manner and at the address indicated in the Drag-Along Notice.

 

5.5           Payment. The consideration per share to be paid to the Dragged Shareholders and the Drag-Along Shareholders pursuant to the proposed Drag-Along Sale shall be determined with reference to Article 65(2) of the Restated Articles.  If the Drag-Along Shareholders or the Dragged Shareholders receive the purchase price for their Shares or such purchase price is made available to them as part of a Drag-Along Sale and, in either case they fail to deliver the relevant signed instruments of transfer and the certificates evidencing their Shares as described in this Section 5, they shall for all purposes be deemed to have agreed to a transfer of their Shares to the purchaser (and the register of members of the Company shall be updated to reflect such status), shall have no voting rights, shall not be entitled to any dividends or other distributions with respect to any Shares held by them, shall have no other rights or privileges as a shareholder of the Company and, in the event of liquidation of the Company, their rights with respect to any consideration they would have received if they had complied with this Section 5, if any, shall be subordinate to the rights of any equity holder.  In addition, the Company shall stop any subsequent transfer of any such shares held by such shareholders.

 

5.6           Minority Purchase Right. The Minority shall deliver a written notice (the “Minority Notice”) to the Drag-Along Shareholders and the Company within 10 Business Days after receipt by the Minority of the Drag Along Notice stating that the Minority intend to purchase such number  of Common Shares held by the Drag-Along Shareholders on the same terms as proposed by the prospective purchaser in the Drag-Along Sale, including, the purchase price and terms of payment associated with such sale and the proposed closing date of such sale.

 

5.7           Closing of Minority Purchase.  At the closing of the transaction to be entered into pursuant to the Minority Purchase Right, the Minority shall remit to each of the Drag-Along Shareholders the same per share consideration (the cash portion of which shall be paid by delivery of a certified check or wire transfer of immediately available funds to an account designated by each Drag-Along Shareholder) for each Share purchased by the Minority pursuant to the Minority Purchase Right against delivery by each of the Drag-Along Shareholders of certificates for all Shares to be sold by the Drag-Along Shareholders, duly endorsed or with duly executed stock powers.

 

5.8           Definition of Trade Sale. For purposes of this Agreement, an “Trade Sale” shall mean (a) a sale, lease, transfer or other disposition of all or substantially all of the assets of the Company, (b) a transfer or an exclusive licensing of all or substantially all of the intellectual property of the

 

43

 

Company, (c) a sale, transfer or other disposition of a majority of the issued and outstanding share capital of the Company or a majority of the voting power of the Company; or (d) a merger, consolidation or other business combination of the Company with or into any other business entity in which the shareholders of the Company immediately after such merger, consolidation or business combination hold shares representing less than a majority of the voting power of the outstanding share capital of the surviving business entity.

 

5.9                                Term. The provisions under this Section 5 shall terminate upon the earlier to occur of:

 

(a)                        the closing of a Qualified Public Offering; and

 

(b)                       a Trade Sale (as defined below).

 

6.                                     ASSIGNMENT AND AMENDMENT.

 

6.1                                 Assignment. Notwithstanding anything herein to the contrary:

 

(a)           Information and Inspection Rights; Registration Rights. The rights of the Investors under Section 1.1 may be assigned to any holder of Preferred Shares, and the registration rights of the Holders under Section 2 may be assigned to any Holder or to any person acquiring Registrable Securities in a permitted transfer provided that no party may assign any of such registration rights to any entity that is organized or domiciled in the PRC; and provided further, that in either case no party may be assigned any of the foregoing rights unless the Company is given written notice by the assigning party stating the name and address of the assignee and identifying the securities of the Company as to which the rights in question are being assigned; and provided, further, that any  such assignee shall receive such assigned rights subject to all the terms and conditions of this Agreement, including without limitation the provisions of this Section 6.

 

(b)           Rights of First Offer; Right of First Refusal; Co-Sale Rights; Drag-Along Rights. The rights of each Investor or each holder of Preferred Shares under Sections 3, 4 and 5 are fully assignable in connection with a permitted transfer of shares of the Company by such Investor or such holder of Preferred Shares, as the case may be; provided, however, that no party may be assigned any of the foregoing rights unless the Company is given written notice by such assigning party at the time of such assignment, stating the name and address of the assignee and identifying the securities of the Company as to which the rights in question are being assigned; and provided, further, that any such assignee shall receive such assigned rights subject to all the terms and conditions of this Agreement, including without limitation the provisions of this Section 6.

 

44

 

6.2           Amendment of Rights.  Any term of this Agreement may be amended only with the written consent of the Company, the holders of a majority of the Preferred Shares, provided, however, that any amendments to any rights of the Founders, other holders of Common Shares, the holders of Series B Shares or the holders of Series C Shares, as the case may be, shall require the prior written approval of the Founders, the holders of at least a majority of then outstanding Common Shares, the holders of a majority of then outstanding Series B Shares or the holders of a majority of then outstanding Series C Shares, as the case may be, each voting together as a separate class; provided, further, that any parties hereto may waive any of its rights hereunder without obtaining the consent of any other party.  Any amendment or waiver effected in accordance with this Section 6.2 shall be binding upon the parties hereto and their respective assigns.

 

7.             CONFIDENTIALITY, NON-DISCLOSURE AND NON-COMPETE.

 

7.1           Disclosure of Terms. The terms and conditions of this Agreement, the Series A Subscription Agreement, the Series B Subscription Agreement, the Series C Subscription Agreement and all exhibits and schedules attached to such agreements, including their existence, and the record and beneficial ownership of the Series C Investors (collectively, the “Financing Terms”) shall be considered confidential information and shall not be disclosed by any party hereto to any third party except in accordance with the provisions set forth below; provided that such confidential information shall not include any information that is in the public domain other than caused by the breach of the confidentiality obligations hereunder.

 

7.2           Press Releases. Any press release issued by the Company shall not disclose any of the Financing Terms and the final form of such press release shall be approved in advance in writing by all of the Investors, which approval shall not be unreasonably withheld. No other announcement regarding any of the Financing Terms in a press release, conference, advertisement,  announcement, professional or trade publication, mass marketing materials or otherwise to the general public may be made without the Investors’ prior written consent.

 

7.3           Permitted Disclosures. Notwithstanding the foregoing, any party may disclose any of the Financing Terms or confidential information obtained from the Company to its current or bona fide prospective investors, employees, investment bankers, lenders, partners, accountants and attorneys on a need-to-know basis, in each case only where such persons or entities are under appropriate nondisclosure obligations (the “Permitted Disclosures”).  Without limiting the generality of the foregoing, the Investors and the Group Company directors designated by the holders of Preferred Shares shall be entitled to disclose the Financing Terms and other information related to the Company or the PRC Subsidiary for the purposes of fund reporting or inter-fund reporting or to their fund manager, other funds managed by their fund manager and their respective auditors, counsel, directors, officers, employees, shareholders or investors, or as

 

45

 

required by law, government authorities, exchanges and/or regulatory bodies, including the SEC (or the equivalent in other jurisdictions).

 

7.4           Legally Compelled Disclosure. In the event that any party is requested or becomes legally compelled (including without limitation, pursuant to securities laws and regulations) to disclose the existence of this Agreement, the Series A Subscription Agreement, the Series B Subscription Agreement, the Series C Subscription Agreement and any of the exhibits and schedules attached to such agreements, or any of the Financing Terms hereof in contravention of the provisions of this Section 7, such party (the “Disclosing Party”) shall provide the other parties (the “Non-Disclosing Parties”) with prompt written notice of that fact and use all reasonable efforts to seek (with the cooperation and reasonable efforts of the other parties) a protective order, confidential treatment or other appropriate remedy.  In such event, the Disclosing Party shall furnish only that portion of the information which is legally required to be disclosed and shall exercise reasonable efforts to keep confidential such information to the extent reasonably requested by any Non-Disclosing Party.

 

7.5           Company Confidential Information.  Each of the Investors agrees that it will keep confidential and will not disclose, divulge or use for any purpose, other than to monitor its investment in the Company, any confidential information obtained from any Group Company pursuant to Section 1 of this Agreement, unless such confidential information (i) is known or becomes known to the public in general (other than as a result of a breach of this Section 7), (ii) is or has been independently developed or conceived by the Investor without use of any Group Company’s confidential information or (iii) is or has been made known or disclosed to the Investor by a third party without a breach of any obligation of confidentiality such third party may have to the Company or any other Group Company; provided, however, that such Investor may disclose confidential information (a) pursuant to Permitted Disclosures as defined in Section 7.3, or (b) to any associate, partner, member, shareholder or wholly owned Subsidiary of such Investor in the  ordinary course of business, or (c) as may otherwise be required by law, provided that such Investor has taken reasonable steps to minimize the extent of any such required disclosure.

 

7.6           Non-Compete.  If any Investor or any of its Affiliates becomes a Competitor (as such term is applicable to such Investor or Affiliates), (A) the right of such Investor to appoint its Director or observer of the Company or any Subsidiary pursuant to Section 1.3(b)(i), Section 1.3(b)(ii) or Section 1.3(b)(iv) of this Agreement shall terminate, as the case may be, (B) the Board of Directors of the Company is entitled to remove the Director or observer so appointed by such Investor in accordance with the terms of this Agreement and the Restated Articles, (C) except as required by law, the right of such Investor to any non-public information of any Group Company shall terminate.

 

46

 

7.7           Other Information. The provisions of this Section 7 shall be in addition to, and not in substitution for, the provisions of any separate nondisclosure agreement executed by any of the parties with respect to the transactions contemplated hereby.

 

7.8           Notices. All notices required under this Section 7 shall be made pursuant to Section 11.1 of this Agreement.

 

8.                                     PROTECTIVE PROVISIONS.

 

8.1           Acts Requiring Majority Approval of Series C Shares.  In addition to such other limitations as may be provided in the Restated Articles, none of the following actions shall be carried out by the Company or any Group Company, except with the prior written consent of the holders of at least a majority (51%) of the then outstanding Series C Shares, voting together as a single class, whether by amendment, merger, amalgamation, consolidation, scheme of arrangement or otherwise (for the purposes of this Section 8, the term “Company” means, unless where wholly inapplicable, the Company and the Subsidiaries):

 

(a)           any amendment or change of the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series C Shares;

 

(b)           any action that authorizes, creates or issues any class of the Company securities having rights, preferences or privileges superior to or on a parity with any Series C Shares or any other securities of the Company;

 

(c)           any action that increases or decreases the authorized number of the Series C Shares or any increase or decrease in the authorized share capital of the Series C Shares; and

 

(d)           any action that reclassifies any outstanding shares into shares having preferences or priority as to dividends or assets senior to or on a parity with the preference of any of the Series C  Shares.

 

8.2           Acts Requiring Super-majority Approval of Series B Shares. In addition to such other limitations as may be provided in the Restated Articles, for as long as the Series B Holders continue to hold at least ten percent (10%) of the Company’s total Shares on an as converted basis, the following acts of the Company shall require the prior written approval of the holder(s) of at least a majority (51%) of the outstanding Series B Shares, voting together as a single class:

 

(a)           any amendment or change of the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, Series B Shares;

 

47

 

(b)           any action that authorizes, creates or issues any class of the Company securities having rights, preferences or privileges superior to or on a parity with any class of Series B Shares or any other securities of the Company;

 

(c)           any action that increases the authorized number of the Series B Shares, or any increase or decrease in the authorized share capital of the Company;

 

(d)           consolidation or merger with or into any other business entity or the sale, lease, transfer or other disposition of all or substantially all the assets of the Company or the license out of all or substantially all of the Company’s intellectual property rights, in each case in transactions with a total consideration value equal to or in excess of US$40,000,000; and

 

(e)           any action that reclassifies any outstanding shares into shares having preferences or priority as to dividends or assets senior to or on a parity with the preference of any of the Series B Shares.

 

8.3           Acts Requiring Majority Approval of Series A-1 Shares. In addition to such other limitations as may be provided in the Restated Articles, for as long as the Series A-1 Holders continue to hold at least ten percent (10%) of the Company’s total Shares on an as converted basis, the following acts of the Company shall require the prior written approval of the holder(s) of at least a majority (51%) of the outstanding Series A-1 Shares, voting together as a single class, which consent shall not be unreasonably withheld, provided however that in no event shall the dividend, voting, liquidation and conversion rights of the Series A-1 Shares as set forth in the Restated Articles be altered without the prior written approval of the holders of a majority of the Series A-1 Shares:

 

(a)           any amendment or change of the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, Series A-1 Shares;

 

(b)           any action that authorizes, creates or issues any class of the Company securities having rights, preferences or privileges superior to or on a parity with any class of Series A-1 Shares or any other securities of the Company;

 

(c)           any action that increases the authorized number of the Series A-1 Shares, or any increase or decrease in the authorized share capital of the Company;

 

(d)           consolidation or merger with or into any other business entity or the sale, lease, transfer or other disposition of all or substantially all the assets of the Company or the license out of all or substantially all of the Company’s intellectual property rights, in each case in transactions with a total consideration value equal to or in excess of US$40,000,000; and

 

48

 

(e)           any action that reclassifies any outstanding shares into shares having preferences or priority as to dividends or assets senior to or on a parity with the preference of any of the Series A-1 Shares.

 

8.4           Acts Requiring Requisite Consent of Series B and Series A-1 Shares.  In addition to such other limitations as may be provided in the Restated Articles, for as long as each of the Series B Holders and the Series A-1 Holders continue to hold at least ten percent (10%) of the Company’s total Shares on an as converted basis, the following acts of the Company shall require the prior written approval of both the holder(s) of at least a majority (51%) of the outstanding Series B Shares, and the holder(s) of at least a majority (51%) of the outstanding Series A-1 Shares, each voting separately as a single class.  (If either the Series B Holders or the Series A-1 Holders do not hold at least ten percent (10%) of the Company’s total Shares, such acts will only require the requisite consent of the class of Series B or Series A-1 holders, as the case may be, which continue to hold such 10% of the total Shares on an as converted basis.)

 

(a)           any action that repurchases, redeems or retires any of the Company’s voting securities other than pursuant to any redemption rights provided in the Restated Articles, or contractual rights to repurchase Common Shares from employees, directors or consultants of the Company or its subsidiaries at the lower of (i) the original purchase price paid by such employees, directors or consultants for such Common Shares or (ii) the fair market value of such Common Shares, which shall be a price set by the Board upon termination of their employment or services or pursuant to the terms of the ESOP or pursuant to the exercise of a contractual right of first refusal held by the Company, or the Company’s Transfer, repurchase and cancellation of the Treasury Shares;

 

(b)           any amendment of the Restated Articles or other constitutional documents;

 

(c)           the dissolution, liquidation or winding up, the initiation of bankruptcy proceedings, or application for appointment of a receiver, judicial manager or the like;

 

(d)           the declaration or payment of any dividend on any Shares of any Group Company or the decision not to declare the distributable profits of any Group Company as dividends;

 

(e)           any change in the number of directors of the Company;

 

(f)            any initial public offering or public offering of any debt or equity securities of any Group Company, unless the offering is a Qualified Public Offering or is otherwise approved by at least four of the five members of the Board.

 

49

 

8.5           Acts Requiring Super-majority Approval of the Board. In addition to such other limitations as may be provided in the Restated Articles, any of the following acts of the Company shall require at least four affirmative votes of the Board, including at least 2 affirmative votes of any of the Series B Director, the Series A-1 Director or the Series A Director:

 

(a)           extension of any loan or advance to, or ownership of any stock or other securities of, any subsidiary or other corporation, partnership, or other entity in excess of US$400,000 unless it is wholly owned by the Company;

 

(b)           extension of any loan or advance to any person, including, without limitation, any employee or director of the Company, except such temporary advances and similar expenditures below US$50,000 as are incurred in the ordinary course of business or under the terms of the ESOP;

 

(c)           directly or indirectly guarantee any indebtedness for any person other than affiliates of the Company, and except for trade accounts of any of the Group Companies arising in the ordinary course of business;

 

(d)           incurrence of any indebtedness in excess of US$100,000 individually or in the aggregate in a series of related transactions during any fiscal year that is not included in the budget approved by the Board, other than trade credit incurred in the ordinary course of business;

 

(e)           the repayment, termination or cancellation of any indebtedness from proceeds to the Company of the sale of Series B Shares pursuant to the Series B Subscription Agreement unless otherwise approved by the Series B Director;

 

(f)            any transaction or series of transactions between the Company and any shareholder, director, officer or employee of the Company or their Affiliates;

 

(g)           any incurrence of any security interest (other than equipment leases or bank line of credit), lien or other encumbrance on any assets of the Company;

 

(h)           any material change in the Company’s business plan, change of the principal business of the Company, entry into new lines of business, or exit of the current line of business of any Group Company;

 

(i)            the approval or amendment of the Company’s annual budget;

 

50

 

(j)            the appointment or removal of the auditors of any Group Company and the determination of their fees, remuneration or other compensation;

 

(k)           any initial public offering or public offering of any debt or equity securities of any Group Company, other than a Qualified Public Offering;

 

(l)            the increase in compensation of any of the five (5) most highly compensated employees of the Company by more than thirty percent (30%) in a twelve (12) month period;

 

(m)          appointment and removal of the CFO of the Company;

 

(n)           the acquisition or leasing of any real estate by the Company, other than commercial office, manufacturing or warehouse space used in the ordinary course of business;

 

(o)           any action that repurchases, redeems or retires any of the Company’s voting securities other than pursuant to any redemption rights provided in the Restated Articles or contractual rights to repurchase Common Shares from employees, directors or consultants of the Company or its subsidiaries at the lower of (i) the original purchase price paid by such employees, directors or consultants for such Common Shares or (ii) the fair market value of such Common Shares, which shall be a price set by the Board upon termination of their employment or services or pursuant to the terms of the ESOP or pursuant to the exercise of a contractual right of first refusal held by the Company, or the Company’s Transfer, repurchase and cancellation of the Treasury Shares;

 

(p)           sale, transfer, license, pledge of or creation of encumbrance over technology or intellectual property of the Company, other than licenses granted in the ordinary course of business; and

 

(q)           consolidation or merger with or into any other business entity or the sale, lease, transfer or other disposition of all or substantially all the assets of the Company or the license out of all or substantially all of the Company’s intellectual property rights.

 

8.6           Acts Requiring Special Approval of the Board. In addition to such other limitations as may be provided in the Restated Articles, any of the following acts of the Company shall require at least four affirmative votes of the Board, provided that any Director with a conflict of interest shall be required to abstain from voting in any Board decisions relating to the actions in which such Director has a conflict of interest:

 

(a)           any investment in excess of US$500,000 other than investments in prime commercial paper, money market funds, certificates of deposit in any international bank having a

 

51

 

net worth in excess of US$100,000,000 or obligations issued or guaranteed by the United States or other sovereign government, in each case having a maturity not exceeding two (2) years (if any such investments are proposed to be made in any person or entity in which any of the Investors is a shareholder, the Director appointed by such Investor shall be deemed to have a conflict of interest for purposes of this Section 8.6(a) and shall abstain from voting in any Board discussion or action regarding such investments);

 

(b)           the investment by the Company in any other entity in excess of US$500,000 individually or in the aggregate during any fiscal year (if any such investments are proposed to be made in any person or entity in which any of the Investors is a shareholder, the Director appointed by such Investor shall be deemed to have a conflict of interest for purposes of this Section 8.6(b) and shall abstain from voting in any Board discussion or action regarding such investments);

 

(c)           the adoption or amendment of the ESOP or any other employee equity incentive plans (if any such proposed adoption or amendment of ESOP or employee equity incentive plans would affect the equity ownership of a Founder in the Group Companies or otherwise relates to a Founder, such Founder Directors shall be deemed to have a conflict of interest for purposes of this Section 8.6(c) and shall abstain from voting in any Board discussion or action regarding actions described in this Section 8.6(c)); and

 

(d)           appointment and removal of the CEO of the Company (Zou Shenglong shall not be deemed to have a conflict of interest for purposes of this Section 8.6(d) and shall be entitled to vote in any Board discussion or action regarding such appointment or removal).

 

8.7           Senior Management Appointment.  The Investors and the Company agree that the power to appoint, remove, dismiss and/or terminate the employment of the Chief Executive Officer (“CEO”) and the Chief Financial Officer of each Group Company shall vest with the Board, requiring consent of four of the five directors, including at least one Founder Director.  The CEO  so appointed by the Board shall have power to appoint, remove, dismiss and/or terminate the employment of the Managing Director, Chief Operating Officer, Chief Technical Officer and Vice Presidents, or their equivalents (all such officers, the “Senior Management Personnel”) and other officers and other employees of any Group Company, other than the Chief Financial Officer (who shall be appointed, removed and/or terminated by the Board), and provided, however, that the remuneration of such Senior Management Personnel shall be subject to the approval of the Board.

 

9.                                     EMPLOYEE OPTIONS.

 

9.1           The Board shall have power to grant options to full-time employees, directors (other than

 

52

 

the Founder Directors and the Founders), officers and consultants of any Group Company to acquire Common Shares (as used in this Section 9, “Options”) provided that:

 

(a)                                   the total number of Shares issued pursuant to such Options and the total number of Shares for the time being subject to such Options shall not in aggregate exceed 26,822,828 Shares (as proportionally adjusted for any combination, consolidation, sub-division or split up of any Common Shares or any new issue of Preferred Shares).

 

(b)                                  the total Share Options granted to any of such employees, directors or officers under the Share Options granted pursuant to this Section 9.1 shall in any event not exceed cumulatively 14.34% of 186,395,936, the total authorized Shares of the Company (as proportionally adjusted for any combination, consolidation, sub-division or split up of any Common Shares or any new issue of Preferred Shares);

 

(c)                                   each such grant thereunder shall be on such terms (including as to conditions of vesting and exercise and exercise price) as shall be approved by the Board, but in any event the Board shall not allow any option to be exercised prior to a Qualified Public Offering or Trade Sale.  Subject to these restrictions, Options shall vest over not less than a four-year period with the first 25% of such shares vesting after twelve (12) months of continued employment or services, and the remaining shares vesting in equal monthly installments over the following thirty-six (36) months.  Each of the parties hereto (with the exception of the Company) hereby waives any right of pre-emption which it may have or acquire in respect of any grant of employee share Options or issue of Shares on exercise pursuant to such option scheme up to the maximum number of Shares;

 

(d)                                  all Share Options granted hereunder vested but not exercised by the holder thereof shall lapse automatically at the expiration of one (1) month after the date of termination of employment, directorship or service, as the case may be, with the Group Company (the Group Company may however make other reasonable arrangements with the service providers who provide services to the Group on an assignment, case-by-case or job basis and are not officers or employees of the Company or subject to any contract of continuous services); and

 

(e)                                   the Company shall retain a “right of first refusal” on employee transfers of Shares issued upon exercise of Options until a Qualified Public Offering or Trade Sale and the right to repurchase any such Shares obtained through exercise of Options held by the employees, directors and consultants granted under this Section 9.1, at a fair price as determined by the auditors of the Company upon termination of employment, directorship or service prior to a Qualified Public Offering or Trade Sale.

 

53

 

10.                               GENERAL PROVISIONS.

 

10.1                           Notices.  Except as may be otherwise provided herein, all notices, requests, waivers and other communications made pursuant to this Agreement shall be in writing and shall be conclusively deemed to have been duly given (a) when hand delivered to the other party, upon delivery; (b) when sent by facsimile at the number set forth in Exhibit E hereto, upon receipt of confirmation of error-free transmission; (c) seven (7) Business Days after deposit in the mail as air mail or certified mail, receipt requested, postage prepaid and addressed to the other party as set forth in Exhibit E; or (d) three (3) Business Days after deposit with an international overnight delivery service, postage prepaid, addressed to the parties as set forth in Exhibit E with next Business Day delivery guaranteed, provided that the sending party receives a confirmation of delivery from the delivery service provider.  Each person making a communication hereunder by facsimile shall promptly confirm by telephone to the person to whom such communication was addressed each communication made by it by facsimile pursuant hereto but the absence of such confirmation shall not affect the validity of any such communication. A party may change or supplement the addresses given above, or designate additional addresses, for purposes of this Section 11.1 by giving the other party written notice of the new address in the manner set forth above.

 

10.2                           Entire Agreement. This Agreement, the Series C Subscription Agreement and any Transaction Agreements (as defined in the Series C Subscription Agreement), together with all the exhibits hereto and thereto, constitute and contain the entire agreement and understanding of the parties with respect to the subject matter hereof and supersedes any and all prior negotiations, correspondence, agreements, understandings, duties or obligations between the parties respecting the subject matter hereof. Without limiting the generality of the foregoing, this Agreement supersedes, in its entirety, the Third Restated Shareholders Agreement, which shall terminate and have no further force or effect whatsoever as of the date of this Agreement, and the parties hereto hereby irrevocably waive any and all rights that they may have against any other party under the Third Restated Shareholders Agreement in exchange for their rights hereunder.

 

10.3                           Governing Law. This Agreement shall be governed by and construed exclusively in accordance with the internal laws of the State of New York.

 

10.4                           Severability. If any provision of this Agreement is found to be invalid or unenforceable, then such provision shall be construed, to the extent feasible, so as to render the provision enforceable and to provide for the consummation of the transactions contemplated hereby on substantially the same terms as originally set forth herein, and if no feasible interpretation would save such provision, it shall be severed from the remainder of this Agreement, which shall remain in full force and effect unless the severed provision is essential to the rights or benefits intended by the parties.  In such event, the parties shall use best efforts to negotiate, in good faith, a substitute, valid and enforceable provision or agreement which most nearly effects the parties’ intent in entering into this Agreement.

 

54

 

10.5                           Third Parties. Nothing in this Agreement, express or implied, is intended to confer upon any person, other than the parties hereto and their permitted successors and assigns any rights or remedies under or by reason of this Agreement.

 

10.6                           Successors and Assigns. Subject to the provisions of Section 6.1, the provisions of this Agreement shall inure to the benefit of, and shall be binding upon, the successors and permitted assigns of the parties hereto.

 

10.7                           Interpretation; Captions. This Agreement shall be construed according to its fair language. The rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be employed in interpreting this Agreement. The captions to sections of this Agreement have been inserted for identification and reference purposes only and shall not be used to construe or interpret this Agreement.  Unless otherwise expressly provided herein, all references to Sections and Exhibits herein are to Sections and Exhibits of this Agreement.

 

10.8                           Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

10.9                           Adjustments for Share Splits, Etc. Wherever in this Agreement there is a reference to a specific number of shares of Series A-1 Shares, Series A Shares, Series B Shares, Series C Shares or Common Shares of the Company, then, upon the occurrence of any subdivision, combination or share dividend of the Series A-1 Shares, Series A Shares, Series B Shares, Series C Shares or Common Shares, the specific number of shares so referenced in this Agreement shall automatically be proportionally adjusted to reflect the effect on the outstanding shares of such class or series of shares by such subdivision, combination or share dividend.

 

10.10                     Future Significant Common Holders.  Except with the written consent of the holders of at least a majority of then outstanding Series C Shares and the holders of at least a majority of then outstanding Series B Shares, each voting together as a separate class, the Company covenants that, until a Qualified Public Offering, it will cause all future holders of more than one percent (1%) of the Common Shares to join this Agreement as a party.  The Parties hereby agree that such future holders may become parties to this Agreement by executing an instrument of accession to this Agreement in a standard and customary form reasonably satisfactory to the Company, without any amendment of this Agreement, pursuant to this Section 11.10.

 

10.11                     Shareholders Agreement to Control. If and to the extent that there are inconsistencies between the provisions of this Agreement and those of the Restated Articles, the terms of this Agreement shall control with respect to each of the shareholders of the Company only.  If appropriate, the parties agree to take all actions necessary or advisable, as promptly as practicable after the discovery of such inconsistency, to amend the Restated Articles so as to

 

55

 

eliminate such inconsistency to the fullest extent permissible by law.  Each Founder shall cause his respective holding company as set forth on Schedule B attached hereto (each, a “Holding Company”), which holds of record the Common Shares as set forth opposite such Holding Company’s name set forth on Schedule B attached hereto, to comply with the provisions of this Agreement applicable to such Holding Company as a holder of Common Shares.

 

10.12                     Aggregation of Shares. All Series A-1 Shares, Series A Shares, Series B Shares, Series C Shares or Common Shares held or acquired by entities or persons which are Affiliates (as defined in Rule 405 under the Securities Act) shall be aggregated together for the purpose of determining the availability of any rights under this Agreement.

 

10.13                     Dispute Resolution.

 

(a)                                  In the event of any dispute arising out of or in connection with this Agreement, including any question regarding its breach, existence, validity, or termination (“Dispute”), the parties shall in good faith attempt to resolve such Dispute as soon as practicable after the complaining party provides notice of such Dispute.  In the event that the Dispute is not resolved between the parties within five (5) business days after receipt of such notice, on the request of the party raising the Dispute, the Dispute shall be referred to and finally resolved by arbitration under the Rules of Arbitration of the International Chamber of Commerce (“ICC”) then in effect.  There shall be three arbitrators, one nominated by the initiating party and the second nominated by the other party, each within fifteen (15) days of receipt of the request for arbitration; the third, who shall act as the chair of the arbitral tribunal, shall be nominated by the two selected arbitrators within twenty (20) days of the confirmation of the second arbitrator.  If any arbitrators are not nominated within these time periods, the ICC International Court of Arbitration shall make the appointment(s).  The place of arbitration shall be Hong Kong.  The language of the arbitral proceedings shall be English.  The arbitral tribunal shall apply the International Bar Association Rules on the Taking of Evidence in International Arbitration (2010).  The arbitrators may award any relief permitted under this Agreement and applicable law; however they may not award punitive, exemplary or multiple damages.  The award shall be rendered within eight (8) months from the selection of the chair of the arbitral tribunal, unless the parties agree to extend this time limit or the arbitral tribunal determines that the interest of justice so requires.  The award shall be final and binding upon the parties as from the date rendered, and shall be the sole and exclusive remedy between the parties regarding any claims, counterclaims, issues, or accounting presented to the arbitral tribunal.  This Agreement and the rights and obligations of the parties shall remain in full force and effect pending the award in any arbitration proceeding hereunder.  The parties agree that any party to this Agreement shall have the right to have recourse to and shall be bound by the Pre-arbitral Referee Procedure of the ICC in accordance with its Rules for a Pre-Arbitral Referee Procedure.

 

56

 

(b)                                 The parties hereto shall initially split the costs of arbitration evenly.  The prevailing party in arbitration shall be entitled to recover from the other party all costs, including of arbitration, and attorneys’ fees incurred in connection with the arbitration.

 

10.14                     Delays or Omissions.  No delay or omission to exercise any right, power or remedy accruing to any party hereto, upon any breach or default of any other party hereto under this Agreement, shall impair any such right, power or remedy of such former party, nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of any similar breach of default thereafter occurring.  Any waiver, permit, consent or approval of any kind or character on the part of any party hereto of any breach of default under this Agreement or any waiver on the part of any party hereto of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing.  All remedies, either under this Agreement, or by law or otherwise afforded to the parties hereto, shall be cumulative and not alternative.

 

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

 

57

 

IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

 

	
 
    	
COMPANY:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
XUNLEI LIMITED
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Shenglong Zou 
    
	
 
    	
Name:  Shenglong Zou 
    
	
 
    	
Title: Chief   Executive Officer and Chairman
    

 

[Signature Page to Fourth Amended and Restated Shareholders Agreement]

 

 

IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

	
 
    	
SUBSIDIARIES:
    
	
 
    	
 
    
	
 
    	
GIGANOLOGY (SHENZHEN) LIMITED (千兆科技(深圳)有限公司)
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Shenglong Zou (with corporate seal)
    
	
 
    	
Name: Shenglong   Zou 
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
SHENZHEN FENGDONG NETWORKING TECHNOLOGIES COMPANY LIMITED (深圳市烽动网络技术有限公司)
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Legal Representative (with   corporate seal)
    
	
 
    	
Name:
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
SHENZHEN XUNLEI NETWORKING TECHNOLOGIES CO LTD (深圳市迅雷网络技术有限公司)
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Shenglong Zou (with corporate seal)
    
	
 
    	
Name: Shenglong   Zou 
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
XUNLEI GAMES DEVELOPMENT   (SHENZHEN) CO., LTD. (深圳市迅雷游戏开发有限公司)
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Legal Representative (with   corporate seal)
    
	
 
    	
Name:
    
	
 
    	
Title:
    
	
 
    	
 
    

 

[Signature Page to Fourth Amended and Restated Shareholders Agreement]

 

 

IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

	
 
    	
SUBSIDIARIES:
    
	
 
    	
 
    
	
 
    	
XUNLEI SOFTWARE (NANJING)   CO., LTD. (南京迅雷软件有限公司)
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Legal Representative (with   corporate seal)
    
	
 
    	
Name:
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
XUNLEI SOFTWARE   (SHENZHEN) CO., LTD. (深圳市迅雷软件有限公司)
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Legal Representative (with   corporate seal)
    
	
 
    	
Name:
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
XUNLEI NETWORKING   (BEIJING) CO., LTD. (北京迅雷网络有限公司)
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Legal Representative (with   corporate seal)
    
	
 
    	
Name:
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
155 NETWORKING (SHENZHEN)   CO., LTD. (深圳市壹伍伍网络技术有限公司)
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Legal Representative (with   corporate seal)
    
	
 
    	
Name:
    
	
 
    	
Title:
    

 

[Signature Page to Fourth Amended and Restated Shareholders Agreement]

 

 

IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

 

	
 
    	
FOUNDERS:
    
	
 
    	
 
    
	
 
    	
/s/ Shenglong Zou 
    
	
 
    	
ZOU   SHENGLONG
    
	
 
    	
 
    
	
 
    	
/s/ Cheng Hao
    
	
 
    	
CHENG HAO
    

 

[Signature Page to Fourth Amended and Restated Shareholders Agreement]

 

 

IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

 

	
 
    	
SERIES C INVESTORS:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
RW Investments LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Paula M. Wardynski
    
	
 
    	
Name: Paula M. Wardynski
    
	
 
    	
Title:   Secretary and Treasurer
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
CRP Holdings Limited
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Legal Representative
    
	
 
    	
Name:
    
	
 
    	
Title:
    

 

[Signature Page to Fourth Amended and Restated Shareholders Agreement]

 

 

IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

	
 
    	
SERIES B INVESTORS:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
CEYUAN VENTURES I, L.P.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Legal Representative
    
	
 
    	
Name:
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
CEYUAN VENTURES ADVISORS FUND, LLC
    
	
 
    	
By:
    	
/s/ Legal Representative
    
	
 
    	
Name:
    
	
 
    	
Title:
    

 

[Signature Page to Fourth Amended and Restated Shareholders Agreement]

 

 

IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

 

	
 
    	
SERIES B INVESTORS:
    
	
 
    	
 
    
	
 
    	
FOR AND ON BEHALF OF
    
	
 
    	
MORNINGSIDE TECHNOLOGY INVESTMENTS LIMITED
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Raymond Long Sing Tang/Hon Kit Bing
    
	
 
    	
Name: Raymond Long Sing Tang/Hon Kit Bing
    
	
 
    	
Title: Authorized   Signatories
    

 

[Signature Page to Fourth Amended and Restated Shareholders Agreement]

 

 

IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

 

	
 
    	
SERIES B INVESTORS:
    
	
 
    	
 
    
	
 
    	
IDG TECHNOLOGY VENTURE INVESTMENT III, L.P.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Chi Sing Ho
    
	
 
    	
Name: Chi Sing Ho
    
	
 
    	
Title:   Authorized Signatory
    

 

[Signature Page to Fourth Amended and Restated Shareholders Agreement]

 

 

IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

 

	
 
    	
SERIES B INVESTORS:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
GOOGLE INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Donald Harrison
    
	
 
    	
Name: Donald Harrison
    
	
 
    	
Title: Vice   President, Deputy General Counsel and Assistant Secretary
    

 

[Signature Page to Fourth Amended and Restated Shareholders Agreement]

 

 

IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

	
 
    	
SERIES B INVESTORS:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
FIDELITY ASIA VENTURES FUND L.P.
    
	
 
    	
By:
    	
Fidelity   Asia Partners, L.P., its General Partner
    
	
 
    	
By:
    	
FIL Asia   Ventures Limited, its General Partner
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Matthew Heath
    
	
 
    	
Name: Matthew Heath
    
	
 
    	
Title:   Director
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
FIDELITY ASIA PRINCIPALS FUND L.P.
    
	
 
    	
By:
    	
Fidelity   Asia Partners, L.P., its General Partner
    
	
 
    	
By:
    	
FIL Asia   Ventures Limited, its General Partner
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Matthew Heath
    
	
 
    	
Name: Matthew Heath
    
	
 
    	
Title:   Director
    
				

 

[Signature Page to Fourth Amended and Restated Shareholders Agreement]

 

 

IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

 

	
 
    	
SERIES A-1 INVESTOR:
    
	
 
    	
 
    
	
 
    	
FOR AND ON BEHALF OF
    
	
 
    	
MORNINGSIDE TECHNOLOGY INVESTMENTS LIMITED
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Raymond Long Sing Tang/Hon Kit Bing
    
	
 
    	
Name: Raymond Long Sing Tang/Hon Kit Bing
    
	
 
    	
Title:   Authorized Signatories
    

 

[Signature Page to Fourth Amended and Restated Shareholders Agreement]

 

 

IN WITNESS WHEREOF, the parties have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

 

	
 
    	
SERIES A INVESTORS:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
IDG TECHNOLOGY VENTURE INVESTMENT III, L.P.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Chi Sing Ho
    
	
 
    	
Name: Chi Sing Ho
    
	
 
    	
Title:   Authorized Signatory
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
JOINWAY INVESTMENTS LIMITED
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Legal Representative
    
	
 
    	
Name: 
    
	
 
    	
Title:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
BRIGHT ACCESS INTERNATIONAL LIMITED
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/ Legal Representative
    
	
 
    	
Name: 
    
	
 
    	
Title:   Authorized Signatory
    

 

[Signature Page to Fourth Amended and Restated Shareholders Agreement]

 

 

SCHEDULE A

 

SUBSIDIARIES

 

Giganology (Shenzhen) Limited (千兆科技(深圳)有限公司)

 

Shenzhen Xunlei Networking Technologies Co., Ltd. (深圳市迅雷网络技术有限公司)

 

Shenzhen Fengdong Networking Technologies Company Limited (深圳市烽动网络技术有限公司)

 

Xunlei Games Development (Shenzhen) Co., Ltd. (深圳市迅雷游戏开发有限公司)

 

Xunlei Software (Nanjing) Co., Ltd. (南京迅雷软件有限公司)

 

Xunlei Software (Shenzhen) Co., Ltd. (深圳市迅雷软件有限公司)

 

Xunlei Networking (Beijing) Co., Ltd. (北京迅雷网络有限公司)

 

155 Networking (Shenzhen) Co., Ltd. (深圳市壹伍伍网络技术有限公司)

 

 

SCHEDULE B

 

COMMON HOLDERS

 

	
Founder
    	
 
    	
Common Holder
    	
 
    	
Founder’s Ownership 
   Percentage in 
   Common Holder
    	
 
    	
Number of 
   Common
   Shares
    
	
Sean Shenglong Zou
    	
 
    	
Vantage   Point Global Limited (a British Virgin Islands company)
    	
 
    	
100
    	
%
    	
44,084,390
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
Hao Cheng
    	
 
    	
Aiden &   Jasmine Limited (a British Virgin Islands company)
    	
 
    	
100
    	
%
    	
17,362,982
    

 

 

EXHIBIT A

 

Schedule of Series A Investors

 

IDG Technology Venture Investment III, L.P.

 

Joinway Investments Limited

 

Bright Access International Limited

 

 

EXHIBIT B

 

Schedule of Series A-1 Investors

 

Morningside Technology Investments Limited

 

 

EXHIBIT C

 

Schedule of Series B Investors

 

Ceyuan Ventures I, L.P.

 

Ceyuan Ventures Advisors Fund, LLC

 

Morningside Technology Investments Limited

 

IDG Technology Venture Investment III, L.P.

 

Google Inc.

 

FIDELITY ASIA VENTURES FUND L.P.

 

FIDELITY ASIA PRINCIPALS FUND L.P.

 

 

EXHIBIT D

 

Schedule of Series C Investor

 

RW Investments LLC

 

CRP Holdings Ltd.

 

 

EXHIBIT E

Notices

 

TO THE GROUP COMPANIES:

 

11th Floor, Shuguang Tower,

South Area,

Nanshan District High-New Technology Park,

Shenzhen,

People’s Republic of China

Fax: (86 755) 2699 3074

Attention: Mr. Zou Shenglong

 

TO IDG TECHNOLOGY VENTURE INVESTMENT III, L.P.:

 

c/o Suite 2815

Wuyang Xingcheng Square, No. 111-115,

Shi You Xing Ma Road,

Guangzhou, the PRC

Fax: (86 20)8700 7035

Attention: YAN Fei

 

TO JOINWAY INVESTMENTS LIMITED:

c/o Ms Grace Young

Rm 3713, The Center

99 Queen’s Road Central

Hong Kong

Fax: (852) 2523 9382

Attention: Ms Grace Young

 

TO BRIGHT ACCESS INTERNATIONAL LIMITED

Suite 301, Block 22, Fulian Garden, Shenzhen, the PRC

Fax : (86 755) 2699 3074

Attention: Wang Fang

 

TO THE SERIES A-1 INVESTOR:

Morningside Technology Investments Limited

c/o MTI Secretarial Services Limited,

22nd Floor, Hang Lung Centre,

2-20 Paterson Street,

Causeway Bay, Hong Kong

 

 

Fax: (852) 2577 3509

Attention: George Chang

 

TO THE SERIES B INVESTORS:

 

For Ceyuan Ventures I, L.P. and Ceyuan Ventures Advisors Fund, LLC:

Maples Corporate Services Limited, Ugland House, 

P.O. Box 309, Grand Cayman, KY1 1104, Cayman Islands

 

With a copy to:

 

No. 35 Qin Lao Hutong,

Dongcheng District, Beijing

100009 P.R.C.

Fax: 86-10-8402 0999

Attention: Chen Yuan

 

For Google Inc.:

1600 Amphitheatre Parkway

Mountain View, California  94043, USA

Fax: +1 (650) 618-1806

Attention: General Counsel

 

with a copy to:

 

Google Inc.

1600 Amphitheatre Parkway

Mountain View, California  94043, USA

Fax: +1 (650) 649-1920

Attention: Donald Harrison, Senior Counsel

 

For FIDELITY ASIA VENTURES FUND L.P. and FIDELITY ASIA PRINCIPALS FUND L.P.:

17th Floor,

One International Finance Centre,

1 Harbour View Street,

Central, Hong Kong

Fax: (852) 2509 0371

Attention: Benson Tam and Yu Qian

 

TO THE SERIES C INVESTORS:

 

RW Investments LLC

 

 

The address, telephone, fax, and email that is on file with the Company, as such information may be amended from time to time by such investor

 

CRP Holdings Limited

 

The address, telephone, fax, and email that is on file with the Company, as such information may be amended from time to time by such investor

 

TO THE FOUNDERS, ZOU SHENGLONG AND CHENG HAO:

 

c/o Shenzhen Xunlei Networking Technologies Co Ltd 

11th Floor ShuGuang Building, South Area

Nanshan District High-New Technology Park

Shenzhen, the PRC

Fax: (86 755) 2699 3074

 

 

EXHIBIT F

 

FORM OF INDEMNIFICATION AGREEMENT

 

 

EXHIBIT G

 

KEY TERMS OF DUAL CLASS STRUCTUREExhibit 4.5

 

Execution Version

 

XUNLEI LIMITED

 

SERIES C PREFERRED SHARE SUBSCRIPTION AGREEMENT

 

THIS SERIES C PREFERRED SHARE SUBSCRIPTION AGREEMENT (the “Agreement”) is made and entered into as of April 14, 2011  by and among Xunlei Limited, an exempted limited liability company organized under the laws of the Cayman Islands (the “Company”), and RW Investments LLC and CRP Holdings Limited (each an “Investor” and collectively “Investors”).  The Company and all of its subsidiaries set forth in Schedule A attached hereto (the “Subsidiaries”) shall be hereinafter collectively referred to as the “Group Companies” and individually as a “Group Company.”

 

RECITALS:

 

A.            The Company is an exempted limited liability company established under the laws of the Cayman Islands on February 3, 2005; and

 

B.            The Investors desire to contribute into the Company the capital in the total amount of US$30,000,000 to be used for capital expenditure, content procurement, merger and acquisition and general working capital needs of the Group Companies.

 

NOW, THEREFORE, in consideration of the foregoing recitals, the mutual promises hereinafter set forth, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

 

1.             AUTHORIZATION, ISSUANCE AND SALE OF SERIES C SHARES

 

1.1.          Authorization. As of the Closing (as defined below), the Company will have authorized the issuance, pursuant to the terms and conditions of this Agreement, of 5,728,264 Series C preferred shares of par value US$0.00025 per share (the “Series C Shares”), having the rights, preferences, privileges and restrictions as set forth in the Fourth Amended and Restated Memorandum of Association and Third Amended and Restated Articles of Association of the Company attached hereto as Exhibit B (the “Restated Articles”).

 

1.2.          Agreement to Subscribe for and Sell Series C Shares. Subject to the terms and conditions hereof, the Company hereby agrees to issue and allot to each Investor, and each Investor hereby agrees, severally and not jointly, to subscribe in cash from the Company for, on the date of Closing (as defined below), that number of Series C Shares opposite the Investor’s name as set forth in Schedule B attached hereto (the “Purchased Shares”) at a purchase price of US$5.24 per share (the “Series C Price”) for the total subscription price set forth opposite such Investor’s name thereon (the “Subscription Price”).

 

2.             CLOSING; DELIVERY; SUBSEQUENT SERIES C SHARES ISSUANCES

 

2.1.          Closing.  Subject to the fulfillment of the conditions to Closing as set forth in Sections 6 and 7, the issuance and allotment of the Series C Shares as provided in Section 1.2 above shall take place remotely via the exchange of documents and signatures on the date of this Agreement, or at such other time, date and place to be mutually agreed upon in writing by the parties hereto (the “Closing”).  The date of the Closing is referred to hereafter as the “Closing Date”.

 

 

2.2.          Closing Deliveries.  On the Closing Date, in addition to any items the delivery of which is made an express closing condition pursuant to Sections 6 and 7, the Company shall issue and deliver to each Investor a share certificate representing the number of Purchased Shares subscribed for by such Investor hereunder, enter such Investor’s name in the Company’s register of members as a holder of the Purchased Shares and deliver to each Investor a certified copy of the register of members reflecting the issuance of the Purchased Shares, against delivery by each Investor to the Company of payment of the Subscription Price by check or wire transfer of immediately available funds to the bank account designated by the Company in a written notice to the Investors at least two (2) Business Days before the Closing.  If at the Closing any of the conditions specified in Section 7 hereof shall not have been fulfilled, the Investors shall, at their election, be relieved of all of its obligations under this Agreement without thereby waiving any other rights it may have by reason of such failure or such non-fulfillment.

 

3.             REPRESENTATIONS AND WARRANTIES OF THE INVESTORs

 

Each Investor, severally and not jointly, hereby represents and warrants to the Company, as of the date hereof and the Closing hereunder, as to itself only that the following representations and warranties are true, accurate and complete.

 

3.1.          Organization, Standing.  The Investor is duly organized, validly existing and in good standing under the laws of the jurisdiction of its formation.

 

3.2.          Authorization. The Investor has full power and authority to enter into and perform its obligations under each of the Transaction Agreements (as defined in Section 4.13 below) to which it is a party.  Each Transaction Agreement to which the Investor is a party has been duly executed and delivered by the Investor.  Each Transaction Agreement, when executed and delivered by the Investor and assuming the due execution and delivery of such Transaction Agreement by the other parties hereto and thereto, will constitute the valid and legally binding obligation of the Investor, enforceable against the Investor in accordance with their respective terms, except as subject to applicable bankruptcy, insolvency, moratorium, reorganization, or similar laws affecting creditors’ rights generally and to general equitable principles.

 

3.3.          No violation, etc.  The execution, delivery and performance of this Agreement by the Investor and the other Transaction Agreements to which it is a party will not: (a) violate any provision of the organizational documents of the Investor; (b) require the Investor to obtain any consent, approval or action of, or make any filing with or give any notice to, any national, provincial, state, local or other governmental agency, department, court, or other authority in any country (“Governmental Authority”) or any other third party pursuant to any agreement to which the Investor is a party; (c) conflict with, or result in any material breach or violation of, any of the terms and conditions of, or constitute (with notice or lapse of time or both) a default under, any contractual obligation to which the Investor is a party; or (d) violate any applicable law or regulation of the country where the Investor is incorporated or any other jurisdiction in which the Investor maintains a business presence.

 

3.4.          Accredited Investor; Non-US Investor.  The Investor either (1) is an Accredited Investor within the definition set forth in Rule 501(a) under Regulation D of the United States Securities Act of 1933, as amended (the “Securities Act”), or (2)is not a “U.S. Person” (as such term is defined in Regulation S promulgated under the Securities Act (“Regulation S”)), and is not subscribing for the Series C Shares for the account or benefit of 

 

2

 

any U.S. Person (as defined in Regulation S).  If the Investor is not a U.S. Person, the Investor agrees to resell such securities only in accordance with the provisions of Regulation S, pursuant to a registration under the Securities Act, or pursuant to an available exemption from registration, and agrees not to engage in hedging transactions with regard to such securities unless in compliance with the Securities Act.

 

3.5.          Purchase for Own Account.  The Purchased Shares and the common shares, par value US$0.00025 per share (the “Common Shares”), of the Company issuable upon conversion of the Purchased Shares (the Common Shares, the “Conversion Shares”) in accordance with the Restated Articles, are being or will be acquired by the Investor for its own account, not as a nominee or agent, and not with a view to or in connection with the sale or distribution of any part thereof.

 

3.6.          Exempt from Registration; Restricted Securities. The Investor understands that the Series C Shares and the Conversion Shares are not, when issued, registered under the Securities Act or registered or listed publicly pursuant to any other applicable securities laws and regulations, on the ground that the sale provided for in this Agreement is exempt from registration under the Securities Act or the registration or listing requirements of any other applicable securities laws and regulations, and that the reliance of the Company on such exemption is predicated in part on the Investor’s representations set forth in this Agreement.  The Investor understands that the Series C Shares and the Conversion Shares are “restricted securities” within the meaning of Rule 144 under the Securities Act and that the Series C Shares and the Conversion Shares are not registered or listed publicly and may be held indefinitely unless they are subsequently registered or listed publicly or an exemption from such registration or listing is available.

 

3.7.          Legends.  If the Investor should in the future decide to dispose of any of such Purchased Shares or Conversion Shares, the Investor understands and agrees that it may do so only in compliance with the Securities Act and applicable state and foreign securities laws, as then in effect.  The Investor agrees to the imprinting, so long as required by law, of a legend on certificates representing all of its Purchased Shares and Conversion Shares to the following effect:

 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY FOREIGN JURISDICTION.  THE SECURITIES MAY NOT BE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE AND FOREIGN SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS.

 

THE SALE, ASSIGNMENT, HYPOTHECATION, PLEDGE, ENCUMBRANCE OR OTHER DISPOSITION (EACH A “TRANSFER”) AND VOTING OF ANY OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE RESTRICTED BY THE TERMS OF THE FOURTH AMENDED AND RESTATED SHAREHOLDERS AGREEMENT, DATED April       , 2011 BY 

 

3

 

AND AMONG THE COMPANY, ITS SUBSIDIARIES AND THE SHAREHOLDERS NAMED THEREIN, A COPY OF WHICH MAY BE INSPECTED AT THE COMPANY’S PRINCIPAL OFFICE.  THE COMPANY WILL NOT REGISTER THE TRANSFER OF SUCH SECURITIES ON THE BOOKS OF THE COMPANY UNLESS AND UNTIL THE TRANSFER HAS BEEN MADE IN COMPLIANCE WITH THE TERMS OF SUCH SHAREHOLDERS AGREEMENT.”

 

4.             REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

 

Except as set forth in the draft Registration Statement on Form F-l that was confidentially submitted on January 14, 2011 to the Securities and Exchange Commission relating to a proposed initial public offering of Common Shares and delivered to each Investor, as such may be amended and supplemented from time to time (the “Draft  Registration Statement”), which shall be deemed to be part of the representations and warranties made hereunder, the Company hereby, represents and warrants to each Investor, as of the date hereof and the Closing (unless any representations and warranties expressly relate to an earlier date, in which case as of such earlier date), that the following representations and warranties are true, accurate and complete.  In this Agreement, any reference to a party’s “knowledge” means such party’s actual knowledge and such knowledge that should have been acquired after due and diligent inquiries of officers and directors of each of the Company and Giganology Shenzhen (as defined below) reasonably believed to have knowledge of the matter in question.

 

4.1.          Organization, Standing and Qualification. The Company has been duly organized, is validly existing and in good standing under, and by virtue of, the laws of the Cayman Islands and has all requisite power and authority to own its properties and assets and to carry on its business as now conducted, and to perform each of its obligations under the Transaction Agreements to which it is a party.  The Company is qualified to do business as a foreign corporation and is in good standing in all other jurisdictions in which its ownership or lease of property or the conduct of its business requires such qualification.

 

4.2.          Capitalization. Immediately prior to the Closing, the authorized share capital of the Company consists of the following:

 

(a)           Common Shares.  A total of 195,504,449 authorized Common Shares, of which 117,515,324 shares are in issue and outstanding, including 56,067,952 shares held by the Company which will be transferred, repurchased and cancelled by the Company as promptly as possible after the Closing without affecting any rights, powers, privileges and preferences of the shareholders of the Company.

 

(b)           Series A and Series A-1 Preferred Shares.  A total of 36,400,000 authorized Series A-1 Preferred Shares of par value US$0.00025 per share (the “Series A-1 Shares”), of which 36,400,000 shares are in issue and outstanding, and a total of 27,932,000 authorized Series A Preferred Shares of par value US$0.00025 per share (the “Series A Shares”), of which 26,416,560 shares are in issue and outstanding.

 

(c)           Series B Shares.  A total of 30,308,284 authorized Series B Preferred Shares of par value US$0.00025 per share (the “Series B Shares” and collectively with the Series C Shares, Series A-1 Shares and Series A Shares, the “Preferred Shares” and 

 

4

 

collectively with the Common Shares, the “Shares”), of which 30,308,284 authorized shares are in issue and outstanding.

 

(d)           Series C Shares.  A total of 5,728,264 authorized Series C Shares, none of which are in issue and outstanding.

 

(e)           Options, Warrants, Reserved Shares.  Except for (i) the conversion privileges of the Preferred Shares, (ii) up to 26,822,828 Common Shares reserved for issuance to employees of, and advisors and consultants to, the Company and the Subsidiaries pursuant to the Company’s 2010 share incentive plan, and (iii) up to 98,853,109 Common Shares reserved for issuance upon the conversion of the Preferred Shares, there are no options, warrants, conversion privileges or other rights, or agreements with respect to the issuance thereof, presently outstanding to purchase any of the shares of the Company.  Except as set forth in the Restated Shareholders Agreement (as defined below), no shares of the Company’s outstanding share capital or shares issuable upon conversion, exercise or exchange of any outstanding options or other convertible, exercisable or exchangeable securities issued or issuable by the Company, are subject to any preemptive rights, rights of first refusal or other rights to purchase such shares (whether in favor of the Company or any other person).  There have been no exercises of the conversion rights of any Series A-1 Shares, Series A Shares, or Series B Shares since the issuance of each such class of securities.

 

(f)            Exhibit A attached hereto sets forth the capitalization of the Company immediately prior to and following the Closing, including the number of shares of the following: (i) issued and outstanding Common Shares; (ii) issued and outstanding stock options, including vesting schedules and exercise price; (iii) stock options cancelled or not yet issued but reserved for issuance; (iv) issued and outstanding Preferred Shares; and (v) warrants and any other share purchase rights, if any.

 

4.3.          Subsidiaries.  (a) The Company does not own or control, directly or indirectly, any interest in any other corporation, association or other business entity, and is not a participant in any joint venture, partnership or similar arrangement, other than the following Subsidiaries: (i) Giganology (Shenzhen) Ltd. (“Giganology Shenzhen”), a wholly owned subsidiary of the Company incorporated under the laws of the People’s Republic of China (the “PRC”), (ii) Shenzhen Xunlei Networking Technologies (“Shenzhen Xunlei”), a variable interest entity of the Company incorporated under the laws of the PRC, and (iii) 155 Networking (Shenzhen) Co, Ltd, Xunlei Networking (Beijing) Co., Ltd., Xunlei Software (Shenzhen) Co., Ltd., Xunlei Software (Nanjing) Co., Ltd., Shenzhen Fengdong Networking Technologies, and Xunlei Games Development (Shenzhen) Co., Ltd., the subsidiaries of Shenzhen Xunlei incorporated under the laws of the PRC.  (b) Each Subsidiary has been duly incorporated, is validly existing and in good standing under the laws of the jurisdiction of its incorporation, and has all requisite power and authority (corporate and other) to own its material properties and assets and to conduct its business as now conducted and to perform each of its obligations under each Transaction Agreement to which it is a party.  Each Subsidiary has, since its establishment, carried on its business in compliance with the business scope set forth in its business license in all material respects.  Each Subsidiary is duly qualified to do business as a foreign corporation in good standing in all other jurisdictions in which its ownership or lease of property or assets or the conduct of its business requires such qualification.  The Constitutional Documents (as defined below) of each Subsidiary comply with the requirements of applicable laws of the jurisdiction of its incorporation and are in full force and effect.  (c) All of the issued and outstanding share capital of Giganology Shenzhen has been duly authorized and validly issued and is fully paid, 

 

5

 

and all such share capital is owned by the Company free from any liens, encumbrances and defects.  (d) All of the issued and outstanding share capital of Shenzhen Xunlei has been duly authorized and validly issued and is fully paid, and such share capital is 20% owned by Guangzhou Shulian Information Investment Co., Ltd. (“Shulian”), 28% by Sean Shenglong Zou, 25% by Hao Cheng, 2% by Fang Wang and 25% by Jianming Shi, free from any liens, encumbrances and defects except the share pledge under which each of Shulian, Sean Shenglong Zou, Hao Cheng, Fang Wang and Jianming Shi has pledged his/its respective share of the registered capital of Shenzhen Xunlei to Giganology Shenzhen in accordance with a share pledge agreement dated November 15, 2006.

 

4.4.          Due Authorization.  All corporate action on the part of the Company, its officers, directors and equity interest holders, if applicable, necessary for (i) the authorization, execution and delivery of, and the performance of all obligations of the Company under the Transaction Agreements to which it is a party, and (ii) the authorization, issuance, and delivery by the Company of all of the Series C Shares being sold under this Agreement at the Closing and the reservation for issuance of the Conversion Shares have been obtained or will have been obtained on or prior to the Closing.  Each of the Transaction Agreements has been duly executed and delivered by the Company that is a party thereto.  Each Transaction Agreement, when executed and delivered by the Company and assuming the due execution and delivery of such Transaction Agreement by the other parties hereto and thereto, and is a valid and legally binding obligation of the Company, enforceable against the Company in accordance with their respective terms, except as subject to applicable bankruptcy, insolvency, moratorium, reorganization, or similar laws affecting creditors’ rights generally and to general equitable principles.

 

4.5.          Valid Issuance of Series C Shares and Conversion Shares.

 

(a)           The Series C Shares, when issued, sold and delivered in accordance with the terms of this Agreement and following receipt of any Subscription Price owing to the Company, will be duly and validly authorized and issued, fully paid and non-assessable.  The Series C Shares, when so issued, sold and delivered, are not and will not be subject to any preemptive rights or rights of first refusal that have not been properly waived or complied with and will not be subject to any liens or other encumbrances, other than restrictions on transfer under applicable securities laws..

 

(b)           The Company will at the Closing have authorized and reserved, and covenants to continue to reserve, a sufficient number of Common Shares for issuance upon conversion of the Series C Shares.  The Conversion Shares will be duly and validly authorized and, upon conversion of the Series C Shares in accordance with the provisions of the Restated Articles, will be duly and validly issued, fully paid and non-assessable.  The Conversion Shares, when so issued, sold and delivered, will not be subject to any preemptive rights or rights of first refusal that have not been properly waived or complied with and will not be subject to any liens or other encumbrances, other than restrictions on transfer under applicable securities laws.

 

(c)           The outstanding capital shares of the Company are duly and validly authorized and issued, fully paid and non-assessable, have been issued in accordance with the Company’s Memorandum and Articles of Association as amended and as in effect at the time of each such issuance, were issued in compliance with all applicable securities laws, and were not issued in violation of any pre-emptive rights, rights of first offer or similar rights.

 

6

 

4.6.          Financial Statements. The Draft Registration Statement includes the Company’s audited consolidated balance sheets as at December 31, 2008, 2009 and 2010, audited consolidated statement of operations, consolidated statements of changes in shareholders’ equity and comprehensive income, and audited consolidated statement of cash flow for the years ended December 31, 2008, 2009 and 2010 (collectively, the above financial statements and any notes thereto, are hereinafter referred to as the “Financial Statements” and December 31, 2010 is the “Balance Sheet Date”).  The Financial Statements were prepared in conformity with US GAAP (as defined in the Restated Shareholders Agreement) throughout the periods indicated, and present fairly the financial position of the Group Companies taken as a whole at the dates thereof and the results of operations of the Group Companies for the periods covered thereby.  The Group Companies maintain and will continue to maintain a standard system of accounting established and administered in accordance with US GAAP.

 

4.7.          Liabilities.  No Group Company has any indebtedness for borrowed money, liabilities, obligations and commitments of any nature, whether accrued, absolute or contingent, and whether due or to become due, that has been directly or indirectly created, incurred, assumed, or guaranteed, or with respect to which any Group Company has otherwise become directly or indirectly liable, except for (i) obligations and liabilities reflected on the Financial Statements, (ii) obligations incurred in the ordinary course of business consistent with past practice that would not be required to be reflected in financial statements prepared in accordance with US GAAP, and (iii) obligations and liabilities disclosed in the Draft Registration Statement.

 

4.8.          Title to Properties and Assets.  Except as disclosed in the Draft Registration Statement, each Group Company has good and marketable title to its properties and assets, whether tangible or intangible, in each case free and clear of any mortgage, pledge, lien, encumbrance, security interest or charge of any kind.  With respect to the property and assets it leases, except as disclosed in the Draft Registration Statement, each Group Company is in compliance with such leases and, to its knowledge, each Group Company holds valid leasehold interests in such assets free of any liens, encumbrances, security interests or claims of any party other than the lessors of such property or assets.

 

4.9.          Status of Proprietary Assets.  For purpose of this Agreement, (i)  “Proprietary Assets” shall mean all patents, patent applications, trademarks, service marks, trade names, domain names, copyrights, copyright registrations and applications and all other rights corresponding thereto, inventions, databases and all rights therein, all computer software including all source code, object code, firmware, development tools, files, records and data, including all media on which any of the foregoing is stored, formulas, designs, trade secrets, confidential and proprietary information, proprietary rights, know-how and processes of a company, and all documentation related to any of the foregoing; and (ii) “Registered Intellectual Property” means all Proprietary Assets of the Group Companies, wherever located, that is the subject of an application, certificate, filing, registration or other document issued by, filed with or recorded by any Government Authority.

 

(a)           Except as disclosed in the Draft Registration Statement, each Group Company (i) has independently developed and owns, free and clear of all material claims, security interests, liens or other encumbrances, or (ii) has a valid right or license to use, all Proprietary Assets, including Registered Intellectual Property, necessary and sufficient to conduct its business as now conducted.  All Registered Intellectual Property is owned by and registered or applied for solely in the name of a Group Company, is valid and subsisting and 

 

7

 

has not been abandoned, and all necessary registration, maintenance and renewal fees with respect thereto and currently due have been satisfied.

 

(b)           Except as disclosed in the Draft Registration Statement, there are no outstanding options, licenses or agreements of any kind relating to the Proprietary Assets, including the Registered Intellectual Property used by the Group Companies, nor is any of the Group Companies bound by or a party to any options, licenses or agreements of any kind with respect to any Proprietary Assets, including the Registered Intellectual Property rights of any other person or entity, except, in either case, with regard to “off-the-shelf” commercially available software products, standard end user, standard support/maintenance agreements, and non-disclosure agreements entered into in the ordinary course of business consistent with past practice.

 

(c)           Each Group Company has taken all commercially reasonable security measures to protect the secrecy and confidentiality of all of its Proprietary Assets material to the conduct of its business as presently conducted.

 

(d)           Except as disclosed in the Draft Registration Statement, none of the Group Companies has, to the knowledge of any of the Group Companies, violated, infringed or misappropriated any Intellectual Property of any other person or entity or has received any written communications alleging that any of the Group Companies has violated, infringed or misappropriated any Intellectual Property of any other person or entity.

 

(e)           Neither the execution nor delivery of this Agreement and any other Transaction Agreement, nor the carrying on of the business as presently conducted of any Group Company by its employees, will, to the knowledge of the Company, conflict with or result in a material breach of the terms, conditions or provisions of, or constitute a default under, any Company Contract (as defined below).

 

4.10.        Material Contracts and Obligations.  Each of the contracts listed as an Exhibit 10 to the Draft Registration Statement (the “Material Contracts”) has been duly authorized, executed and delivered by the Group Company or Group Companies which are parties to such Material Contracts, as the case may be, and each such Group Company has, to the extent applicable, taken all necessary corporate actions to authorize the performance thereof, and each such Group Company had the corporate power and capacity to enter into and to perform its obligations under such Material Contracts.  The execution, delivery and performance of each of the Material Contracts to which such Group Company is a party will not result in any violation of any applicable laws, and all approvals, permits or licenses required, and all other steps necessary, for the performance and enforcement of the Material Contracts have been obtained or completed and are in full force and effect.

 

4.11.        Litigation.  Except as disclosed in the Draft Registration Statement and to the knowledge of each Group Company, there are no pending notices, claims, actions, suits, or proceedings (including any inquiries or investigations by any Governmental Authority, domestic or foreign), against or affecting any Group Company, any of its properties or assets, or any of its officers, directors or employees with respect to such Group Company’s businesses, which, if determined adversely to such Group Company or any of such officers, directors, employees or consultants, (i) would individually or in the aggregate have a material adverse effect on the condition (financial or otherwise), results of operations, business, operations, properties, assets (including intangible assets), liabilities or prospects of the Group Companies taken as a whole (a “Material Adverse Effect”), or (ii) would materially and adversely affect 

 

8

 

the ability of the Company to perform its obligations under the Transaction Agreements; and no such notices, claims, actions, suits, or proceedings (including any inquiries or investigations by any Governmental Authority, domestic or foreign) are threatened or, to the Company’s knowledge, contemplated.

 

4.12.        Compliance with Laws; Consents and Permits.  Each of the Group Companies is, and has been, in compliance in all respects with all applicable laws, except for such non-compliance that would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.  None of the Group Companies has conducted any activity that may, with or without notice or lapse of time or both, constitute a violation of, or a failure to comply with, any applicable law, statute, rule, regulation, order or restriction of any domestic or foreign government or any instrumentality or agency thereof in respect of the conduct of its business or the ownership of its properties.  All consents, permits, approvals, orders, authorizations or registrations, qualifications, designations, declarations or filings by or with any Governmental Authority and any third party which are required to be obtained or made by any Group Company in connection with the valid execution, delivery and performance of the Transaction Agreements, and the consummation of the transaction contemplated by the Transaction Agreements, have been duly obtained or made prior to and are in full force and effect as of the Closing.  Each Group Company has obtained and is in compliance with all approvals, permits, licenses and any similar authority necessary for the due and proper establishment and the conduct of its business as currently conducted, the absence of which would be reasonably likely to have a Material Adverse Effect.  There is no term or provision of any mortgage, indenture, contract, agreement or instrument to which any Group Company is a party or by which any of them is bound, or, to the knowledge of the Group Companies, of any judgment, decree, order, statute, rule or regulation applicable to or binding upon any Group Company, that materially adversely affects or, so far as the Company may now foresee, in the future is reasonably likely to materially adversely affect, the business, prospects, condition, affairs or operations of any Group Company or any of their respective properties or assets.  None of the Group Companies is in default under any of such approvals, permits, licenses or other similar authority, nor is it in receipt of any letter or notice from any relevant Governmental Authority notifying revocation of any such approvals, permits or licenses issued to it for non-compliance or the need for compliance or remedial actions in respect of the activities carried out directly or indirectly by such Group Company.

 

4.13.        Compliance with Constitutional Documents and Other Agreements; No violations, etc.  None of the Group Companies is in, nor shall the conduct of its business as currently or proposed to be conducted result in, any violation, breach or default of any term of its constitutional documents which may include, as applicable, memoranda and articles of association, by-laws, joint venture contracts, and the like (the “Constitutional Documents”), or in any material respect of any term or provision of any mortgage, indenture, lease contract, agreement or instrument to which the Group Company is a party or by which it may be bound, including, without limitation, the Material Contracts (all such instruments, the “Group Company Contracts”) or of any provision of any judgment, decree, order, statute, rule or regulation applicable to or binding upon the Group Company.  The execution, delivery and performance by each Group Company of and compliance by each Group Company with this Agreement, the Restated Shareholders Agreement and any other agreements or documents attached hereto as an exhibit or schedule and to which such Group Company is a party in connection with the transactions contemplated hereunder and thereunder (collectively, the “Transaction Agreements”) and the consummation of the transactions contemplated hereby and thereby will not (i) violate any provision of its Constitutional Documents, (ii) require 

 

9

 

such Group Company to obtain any consents, permits, approvals, orders, authorizations or registrations, qualifications, designations, declarations or filings, by, from or with any Governmental Authority, (iii) result in any violation, breach or default, or be in conflict with, or give any person rights of termination, amendment, acceleration or cancellation, with or without the passage of time or the giving of notice or both, under any Group Company’s Constitutional Documents or any Group Company Contracts, (iv) constitute a violation of any statutes, laws, regulations or orders, or (v) constitute an event which results in the creation of any lien, charge or encumbrance upon any asset of any Group Company.

 

4.14.        Disclosure; No More Favorable Terms.  The Company has fully provided the Investors with all the information that the Investors have reasonably requested for deciding whether to subscribe for the Series C Shares.  No representation or warranty by the Company in this Agreement and no information or materials provided by the Company to the Investors in connection with such Investors’ due diligence investigation of the Group Companies or the negotiation and execution of this Agreement contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances in which they are made, not misleading.  To the Company’s knowledge, there are no facts which would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect that have not been set forth in this Agreement, the Exhibits hereto, the other Transaction Agreements or in other documents delivered to the Investors or their counsel or agents in connection herewith.  The Company has not entered into any memorandum of understanding, side letter, contract or other agreement with any other person or entity purchasing or intending to purchase Series C Shares, which contains terms more favorable than, or otherwise provides for rights, privileges, preferences or powers senior to, those to which the Investors shall be entitled under the Transaction Agreements (such more favorable or senior terms, rights, privileges, preferences or powers, the “More Favorable Terms”).

 

4.15.        Accounting.  The Company maintains a standard system of accounting established and administered in accordance with US GAAP and will maintain a standard system of accounting established and administered in conformity with US GAAP.

 

4.16.        Activities Since Balance Sheet Date.  Except as specifically set forth in this Agreement or in the Draft Registration Statement and with respect to the Closing, since the Balance Sheet Date, with respect to each Group Company, other than the transactions as contemplated in accordance with the Transaction Agreements, there has not been:

 

(a)           any change in the assets, liabilities, financial condition or operating results of the Group Companies, except changes in the ordinary course of business that have not been, individually or in the aggregate, materially adverse;

 

(b)           any material change in the contingent obligations of the Group Companies by way of guarantee, endorsement, indemnity, warranty or otherwise;

 

(c)           any damage, destruction or loss, whether or not covered by insurance, having a Material Adverse Effect;

 

(d)           any waiver by any Group Company of a valuable right or of a material debt;

 

10

 

(e)           any satisfaction or discharge of any lien, claim or encumbrance or payment of any obligation by any Group Company, except such satisfaction, discharge or payment made in the ordinary course of business that is not material to the assets, properties, financial condition, operating results or business of such Group Company;

 

(f)            any change or amendment to a Material Contract, except for changes or amendments which are expressly provided for or disclosed in this Agreement;

 

(g)           any material change in any compensation arrangement or agreement with any Key Employee as set forth in Exhibit E (the “Key Employees”), officer, contractor or director not approved by the applicable Group Company’s board of directors or comparable governing body;

 

(h)           any sale, assignment or transfer of any Proprietary Assets or other material intangible assets of any Group Company;

 

(i)            any resignation or termination of any Key Employee;

 

(j)            any mortgage, pledge, transfer of a security interest in, or lien created by the Company, with respect to any of its material properties or assets, except liens for taxes not yet due or payable;

 

(k)           any debt, obligation, or liability incurred, assumed or guaranteed by any Group Company individually in excess of US$1,000,000 or in excess of US$2,500,000 in the aggregate;

 

(l)            any declaration, setting aside or payment or other distribution in respect of any Group Company’s share capital or registered capital, or any direct or indirect redemption, purchase or other acquisition of any of such share capital or registered capital by any Group Company;

 

(m)          any failure to conduct business in the ordinary course, consistent with each Group Company’s reasonably prudent past practices; or

 

(n)           any agreement or commitment by any Group Company to do any of the things described in this Section 4.16.

 

4.17.        Tax Matters.  There have been no examinations or audits of any tax returns or reports of any of the Group Companies by any applicable governmental agency.  Each Group Company has filed all tax returns required to have been filed by it and except as otherwise disclosed in the Draft Registration Statement, there is no tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or any of the Group Company or any of their respective properties or assets that has had a Material Adverse Effect.  None of the Group Companies is subject to any waivers of applicable statutes of limitations with respect to taxes for any year.  Each Group Company has withheld individual income taxes and adequately paid mandatory contributions to the statutory welfare or social security funds on behalf of all its employees in material compliance with the applicable regulations in each respective jurisdiction such that there shall be no material default or underpayment in respect of individual income taxes and mandatory contributions to the statutory social security funds. Since its formation, none of the Group Companies has incurred any taxes, assessments or governmental charges other than in its ordinary course of

 

11

 

business and each Group Company has made adequate provisions on its books of account for all taxes, assessments and governmental charges with respect to its business, properties and operations for such period.

 

4.18.        Interested Party Transactions.  To the knowledge of the Group Companies, no officer, employee, consultant or director of a Group Company, has any agreement, understanding, proposed transaction with, or is indebted to, any Group Company, nor is any Group Company indebted (or committed to make loans or extend or guarantee credit) to any of them (other than for accrued salaries, reimbursable expenses or other standard employee benefits).   To the knowledge of the Group Companies, no officer, employee, consultant or director of a Group Company, has had, either directly or indirectly, a material interest in: (a) any person or entity which purchases from or sells, licenses or furnishes to the a Group Company any goods, property, intellectual or other property rights or services; (b) any person that directly or indirectly competes with any Group Company (other than ownership of less than five percent (5%) of the stock of publicly traded companies); or (c) any contract or agreement to which a Group Company is a party or by which it may be bound or affected.

 

4.19.        Employee Matters.  Except as disclosed in the Draft Registration Statement, each Group Company has complied in all material aspects with all applicable employment and labor laws, including, without limitation, laws and regulations pertaining to wages, compensation, hours, working conditions, welfare funds, social benefits, medical benefits, insurance, retirement benefits, pensions or the like.  None of the Group Companies is aware that any officer of any Group Company or any Key Employee intends to terminate their employment, nor does any Group Company have a present intention to terminate the employment of any such officer or Key Employee.  To the knowledge of the Group Companies, none of the Key Employees is obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would interfere with the use of his or her best efforts to promote the interests of the Group Companies.  Except as set forth in the Draft Registration Statement, the Group Companies are not a party to or bound by any currently effective deferred compensation arrangement, bonus plan, incentive plan, profit sharing plan, retirement agreement or other employee compensation plan or agreement.  To the knowledge of the Group Companies, none of their respective employees are subject to any non-compete or similar agreements other than with the Group Companies, and no employee of any of the Group Companies is in violation of any contract or covenant (either with any Group Company or with another entity) relating to employment, patent, other proprietary information disclosure, non-competition, or non-solicitation.

 

4.20.        SAFE Registration.  Each holder or beneficial owner of any securities of a Group Company or Holding Company (each, a “Security Holder”), who is a “Domestic Resident” as defined in the Notice on Relevant Issues Concerning Foreign Exchange Administration for Domestic Residents to Engage in Overseas Financing and Round Trip Investment via Overseas Special Purpose Companies issued by the PRC State Administration of Foreign Exchange (“SAFE”) on October 21, 2005 (“Circular 75”) and the Implementing Rules for Circular 75 issued by SAFE on May 31, 2007 (“Notice 106”) and is subject to any of the registration or reporting requirements of Circular 75, will have complied with all reporting and/or registration requirements (including, without limitation, filings of  amendments to existing registrations) under Circular 75, Notice 106 and any other applicable SAFE rules and regulations (collectively, the “SAFE Rules and Regulations”), and will have made all oral or written filings, registrations, reporting or any other communications 

 

12

 

required by SAFE or any of its local branches.  No Group Company has, nor, to the knowledge of the Company and Giganology Shenzhen, no Security Holder has, received any oral or written inquiries, notifications, orders or any other form of official correspondence from SAFE or any of its local branches with respect to any actual or alleged non-compliance with SAFE Rules and Regulations.

 

4.21.        Anti-Bribery, Anti-Corruption, Anti-Money Laundering and Sanctions; Absence of Government Interests.

 

(a)           Each Group Company and, to its knowledge, its respective directors, officers, employees, agents and other persons acting on their behalf (collectively, the “Representatives”) are familiar with and are and have been in compliance with all applicable laws relating to anti-bribery, anti-corruption, anti-money laundering, record keeping and internal control laws, including, without limitation, the Foreign Corrupt Practices Act of the United States of America, as amended from time to time (the “FCPA”).  Furthermore, no public official (i) holds an ownership or other economic interest, direct or indirect, in any of the Group Companies or in the contractual relationship formed by this Agreement, or (ii) serves as an officer, director or employee of any Group Company.

 

(b)           No Group Company or, to its knowledge, any of its Representatives has ever been found by a Governmental Authority to have violated any criminal or securities law or is subject to any indictment or any government investigation for bribery.  To the knowledge of each Group Company, none of the beneficial owners of any equity securities or other interest in any Group Company or the current or former Representatives of any Group Company are or were public officials.  No public official has been involved on behalf of a Governmental Authority in decisions as to whether any Group Company would be awarded business or that otherwise could benefit any Group Company, or in the appointment, promotion, or compensation of persons who will make such decisions.

 

(c)           To the knowledge of the Group Companies, (a) no Group Company or any of its Representatives is a Prohibited Person, and no Prohibited Person will be given an offer to become an employee, officer, consultant or director of any Group Company, and (b) no Group Company has conducted or agreed to conduct any business, or entered into or agreed to enter into any transaction with a Prohibited Person.  For purposes hereof, the term “Prohibited Person” means any Person that is (1) a national or resident of any U.S. embargoed or restricted country, (2) included on, or affiliated with any Person on, the United States Commerce Department’s Denied Parties List, Entities and Unverified Lists; the U.S. Department of Treasury’s Specially Designated Nationals, Specially Designated Narcotics Traffickers or Specially Designated Terrorists, or the Annex to Executive Order No. 13224; the Department of State’s Debarred List; UN Sanctions, (3) a member of any PRC military organization, or (4) a Person with whom business transactions, including exports and re-exports, are restricted by a U.S. Governmental Authority, including, in each clause above, any updates or revisions to the foregoing and any newly published rules.

 

5.             COVENANTS OF THE COMPANY

 

The Company covenants to each Investor as follows:

 

5.1.          Use of Proceeds from Capital Contribution by the Investors. The aggregate Subscription Price shall be used to meet capital expenditures and general working capital needs of the Group Companies, such as for content procurement or merger and acquisition. 

 

13

 

None of the Subscription Price shall be used to repurchase, redeem or cancel any securities, repay or terminate indebtedness, or to make any payments to shareholders, directors or officers of the Company or any Affiliate (as such term is defined in Rule 405 of the Securities Act) of the Company or any of the foregoing unless in connection with a bona fide arms-length transaction approved by the Board of Directors of the Company (the “Board of Directors”).

 

5.2.          Business of the Company. Unless otherwise approved by the Board of Directors, the business of the Company shall be restricted to the holding and management of its equity interest in, and certain Proprietary Assets and other assets used by, the Subsidiaries.

 

5.3.          Amended and Restated Shareholders Agreement.  The Company should use its commercially reasonable efforts to ensure that each of its existing shareholders shall execute and deliver to execute and deliver, the Fourth Amended and Restated Shareholders Agreement substantially in the form attached hereto as Exhibit C (the “Restated Shareholders Agreement”).

 

5.4.          Additional Covenants.

 

(a)           Except as required by this Agreement, no contract or commitment shall be entered into by a Group Company at any time after the date hereof and prior to the Closing, without the written consent of the Investors, except that each Group Company may carry on its respective business in the same manner as heretofore and may pass resolutions and enter into contracts for so long as they are effected in the ordinary course of business.

 

(b)           If at any time after the date hereof and before the Closing, the Company shall know of any fact or event which:

 

(i)            is in any way materially inconsistent with any of the representations and warranties given by the Company under Section 4 hereof,

 

(ii)           suggests that any representation or warranty under Section 4 hereof may not be as represented or warranted or may be misleading or any covenant, condition or agreement to be complied with or satisfied by the Company may fail to be complied with or satisfied, or

 

(iii)          might affect the willingness of the Investors to subscribe for the Series C Shares,

 

the Company shall give immediate written notice thereof to the Investors, in which event the Investors may, within ten (10) Business Days (as defined in the Restated Shareholders Agreement) after receiving such notice, terminate this Agreement by written notice without any penalty, liability or obligations whatsoever, and this Agreement shall be of no further force or effect immediately thereafter; provided, however, nothing herein shall relieve any party from liability for any breach of this Agreement or otherwise limit or affect any remedies available to the Investors.

 

(c)           If the Company shall, after the date hereof, enter into any  memorandum of understanding, side letter, contract or other agreement with any other person or entity purchasing or intending to purchase Series C Shares, which would contain any More Favorable Terms, then, subject to the written approval of the Investors, the Company shall, 

 

14

 

concurrently with the entering into of such memorandum, letter, contract or other agreement, amend or supplement the applicable Transaction Agreements or enter into other agreements as necessary or appropriate so that the Investors shall receive all of the More Favorable Terms.

 

5.5.          Reservation of Conversion Shares.  The Company covenants to at all times reserve sufficient Common Shares or, if the reservation is insufficient, to take all actions necessary to authorize such additional Common Shares, for issuance upon conversion of all Series C Shares.

 

5.6.          Fulfillment of Closing Conditions.  The Company shall use its best reasonable efforts to fulfill all closing conditions contained in Section 7 of this Agreement.

 

5.7.          SAFE Registration Amendment Post Closing.  To the extent required under applicable law, each existing Security Holder shall apply for and obtain an amendment to such holder’s SAFE registration certificates with the applicable Governmental Authorities within thirty (30) days after the Closing in form and substance reasonably satisfactory to the Investors.  After the date hereof, the Company and Giganology Shenzhen shall use reasonable best efforts to promptly obtain a Power of Attorney in the form attached hereto as Exhibit H from any Security Holder who is subject to any of the registration or reporting requirements of the SAFE Rules and Registrations, and shall use reasonable best efforts to cause the designated representative under such Power of Attorney to promptly take such actions and execute such instruments on behalf of such Security Holder to comply with the applicable SAFE registration or reporting requirements under SAFE Rules and Regulations.

 

5.8.          Compliance with Laws.

 

(a)           The Company shall not, and shall cause any Subsidiary, any of their respective officers, employees, directors, representatives, distributors, resellers or agents not to, make, offer, promise, authorize or condone any Prohibited Payment in connection with the activities of the Group Companies.  A “Prohibited Payment” means any gift, transfer or payment of any thing of value that is (A) to the extent the Company is subject to the FCPA, made in violation of the FCPA, anti-corruption laws of the PRC or other applicable laws, (B) made to any Public Official with the intent or purpose of: (i) influencing any act or decision of such Public Official in his official capacity, (ii) inducing such Public Official to do or omit to do any act in violation of the lawful duty of such Public Official, (iii) securing any improper advantage, or (iv) inducing such Public Official to use his influence with a government or instrumentality thereof, political party or international organization to affect or influence any act or decision of such government or instrumentality, political party or international organization, in order to assist any of the Group Companies in obtaining or retaining business for or with, or directing business to, any person, or (c) made to any person while aware of a high probability that all or any portion of such thing of value would be paid, promised, offered or given to any Public Official with the intent or purpose described in paragraph (B) above.  Prohibited Payment shall not include any gift, transfer or payment of any thing of value that is expressly permitted by the written laws and regulations of the recipient’s country.  For purposes of this Section 5.8, the term the term “Governmental Authority” means any court, tribunal, arbitrator, authority, agency, commission, official or other body or instrumentality exercising executive, legislative, judicial, regulatory or  administrative functions in the United States, PRC or any other country or any state, province, region, county, city or other political subdivision of any country, and the term “Public Official” means any executive, official, or employee of a Governmental Authority, political 

 

15

 

party or member of a political party, political candidate; executive, employee or officer of a public international organization; or director, officer or employee or agent of a wholly owned or partially state-owned or controlled enterprise, including a PRC state-owned or controlled enterprise.  For the avoidance of doubt, the term Public Official shall include any employee of official of a media, telecommunications or internet company, entity, firm or institution owned or controlled by a Government Authority.

 

(b)           As soon as practicable after the date hereof, the Company shall use commercially reasonable efforts to adopt a compliance program and a code of business ethics to establish internal control and reporting mechanisms to prevent, detect, identify, investigate and correct unethical, illegal or otherwise improper business practices, including violations of applicable anti-bribery laws, including, without limitation, the FCPA.  To the extent that FCPA becomes applicable to the Company, each Group Company shall provide FCPA training and anti-bribery training to its employees, officers and directors on a regular basis.  After the Company completes an initial public offering on a national securities exchange in the United States, the Company shall comply with the accounting control provisions of the FCPA and other applicable securities regulations and laws.

 

5.9.          United States Tax Matters.

 

(a)           The Company is properly classified as a corporation for U.S. tax purposes.  Neither the Company nor any Subsidiary will take any action inconsistent with the treatment of the Company as a corporation for U.S. tax purposes or elect to be treated as an entity other than a corporation for U.S. tax purposes.

 

(b)           The Company shall use, and shall cause each Subsidiary to use, its best efforts to arrange its management and business activities in such a way that neither the Company nor any Subsidiary is treated as resident for tax purposes, or is otherwise subject to income tax in, a jurisdiction other than the jurisdiction in which they have been organized.

 

(c)           The Company shall use its best efforts to avoid the Company being or becoming a “passive foreign investment company” (“PFIC”) within the meaning of Section 1297 of the U.S. Internal Revenue Code of 1986, as amended (the “Code”).  From time to time, the Company shall promptly provide the Investors with any information reasonably requested by the Investors to enable the Investors to file a “Protective Statement” pursuant to Treasury Regulation Section 1.1295-3.  Within forty-five (45) days from the end of each taxable year of the Company, the Company shall determine whether the Company was a PFIC in such taxable year (including whether any exception to PFIC status may apply).  If the Company determines that the Company was a PFIC in such taxable year (or if a government authority or the Investors inform the Company that it has so determined), the Company shall, within sixty (60) days from the end of such taxable year, provide the following information to the Investors: (1) all information reasonably available to the Company to permit such PFIC Shareholder to (i) accurately prepare its U.S. tax returns and comply with any other reporting requirements, if any, arising from its investment in the Company and relating to the Company’s classification as a PFIC and (ii) make any election (including, without limitation, a “qualified electing fund” election under Section 1295 of the Code), with respect to the Company; and (2) a completed “PFIC Annual Information Statement” as described under Treasury Regulation Section 1.1295-1(g).

 

(d)           The Company shall comply and shall cause each Subsidiary to comply with all record-keeping, reporting, and other requirements that the Investors inform the 

 

16

 

Company must be satisfied to enable the Investors to comply with any applicable U.S. federal and state tax laws.  In addition to providing the information otherwise set forth in this Section 5.9, the Company shall provide the Investors with (1) any information reasonably requested by the Investors to enable the Investors to comply with any applicable U.S. federal, state, and local tax laws and (2) reasonable access to, and the cooperation of, the Company’s employees, accountants and other advisors, in each case to allow the Investors to comply with applicable U.S. federal, state, and local tax laws.

 

(e)           The costs incurred by the Company in providing the information that it is required to provide, or is required to cause to be provided, and the costs incurred by the Company in taking the actions, or causing the actions to be taken, as described in this Section 5.9 shall be borne by the Company.

 

(f)            Nothing in this Section 5.9 shall prevent the Company from issuing shares or other securities or otherwise structuring and conducting its operations and the operations of its subsidiaries in a manner that, in the exercise of the reasonable discretion of the Board of Directors, is in the best interest of the Company.

 

5.10.        Content Protection Measures.  At the earliest possible opportunity, the Company will use commercially reasonable efforts to address claims of US copyright owners regarding alleged copyright infringement against any Group Company.

 

6.             CONDITIONS TO THE OBLIGATIONS OF THE COMPANY AT THE CLOSING

 

The obligations of the Company under this Agreement at the Closing are subject to the fulfillment, unless waived in writing by the Company, at or prior to the Closing, of the following conditions:

 

6.1.          Representations and Warranties True and Correct. The representations and warranties made by the Investors in Section 3 hereof shall be true, correct and complete when made, and shall be true, correct and complete as of the Closing Date with the same force and effect as if they had been made on and as of such date.

 

6.2.          Payment of Subscription Price. Each Investor shall have delivered to the Company the Investor’s Subscription Price in accordance with Sections 1 and 2.

 

6.3.          Securities Exemptions.  The issuance and allotment of the Series C Shares to each Investor pursuant to this Agreement and the issuance of the Conversion Shares shall be exempt from the registration and/or qualification requirements of all applicable securities laws.

 

6.4.          Execution of the Restated Shareholders Agreement. Each Investor shall have executed and delivered to the Company the Restated Shareholders Agreement.

 

6.5.          Investor Approvals.  Each Investor shall have obtained all necessary corporate or applicable approvals, consents and qualifications for its execution, delivery and performance of its obligations in/or contemplated under the Transaction Agreements and applicable laws.

 

17

 

7.             CONDITIONS TO INVESTORS’ OBLIGATIONS AT THE CLOSING

 

The obligations of the Investors under this Agreement at the Closing are subject to the fulfillment, unless waived in writing by the Investors, at or before the Closing, of the following conditions:

 

7.1.          Representations and Warranties True and Correct. The representations and warranties of the Company contained in Section 4 shall be true, correct and complete when made, and shall be true, correct and complete as of the Closing Date with the same force and effect as if they had been made on and as of such date.

 

7.2.          Performance of Obligations. The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement and the other Transaction Agreements that are required to be performed or complied with by it on or before the Closing.

 

7.3.          Proceedings and Documents. All corporate and other proceedings in connection with the transactions contemplated hereby and all documents and instruments incident to such transactions to be passed, executed and/or delivered by the Company, including, without limitation, the Transaction Agreements,  shall be satisfactory in substance and form to the Investors, and the Investors shall have received all such counterpart originals or certified or other copies of such documents as it may reasonably request, including, without limitation:

 

(a)           (i) Resolutions of the board of directors and the shareholders of the Company, authorizing and approving all matters in connection with this Agreement and the other Transaction Agreements and the transactions contemplated hereby and thereby, (ii) resolutions of the board of directors of a Subsidiary and resolutions of the shareholders of a Subsidiary (other than Giganology Shenzhen), authorizing and approving all matters in connection with the Transaction Agreements to which such Subsidiary is a party, (iii) the Constitutional Documents of each Group Company as then in effect and (iv) the most recent good standing certificate with respect to the Company from the Registrar of Companies of the Cayman Islands, and a business license of each Subsidiary with the most recent annual inspection stamps of the applicable local branch of SAIC, each attached to a certificate executed by an officer or a director of the Company as of the Closing Date;

 

(b)           A certificate issued by a director of the Company as to the incumbency and signatures of the officers of the Company executing documents on behalf of the Company in connection with the transactions contemplated by this Agreement; and

 

(c)           A counterpart of a cross-receipt reasonably acceptable to the Investors, a form of which has been provided to the Investors or their counsel before the date hereof, duly executed on behalf of the Company.

 

7.4.          Reservation of Conversion Shares.  The Conversion Shares issuable upon conversion of the Series C Shares shall have been duly authorized and reserved for issuance upon such conversion.

 

7.5.          Consents and Waivers.  The Company shall have obtained any and all consents and waivers necessary for consummation of the transactions contemplated by this Agreement, including, but not limited to, (i) all permits, authorizations, approvals, consents  or permits of any Governmental Authority, and (ii) the waiver by the existing shareholders of the Company of any anti-dilution rights, rights of first refusal, pre-emptive rights and all 

 

18

 

similar rights that may exist in connection with the issuance of Series C Shares and the Conversion Shares.

 

7.6.          Compliance Certificate.  The Company shall deliver to the Investors a certificate, dated the Closing Date, executed by the chief executive officer of the Company certifying that the conditions specified in this Section 7 have been fulfilled and stating, where applicable, that there shall have been no material adverse change in the business, affairs, prospects, operations, properties, assets, liabilities or condition (financial or otherwise) of each of the Group Companies since the Balance Sheet Date.

 

7.7.          Securities Exemptions.  The issuance and allotment of the Purchased Shares to the Investors pursuant to this Agreement and the issuance of the Conversion Shares shall be exempt from the registration and/or qualification requirements of all applicable securities laws.

 

7.8.          Amendment to Constitutional Documents.  The Restated Articles which set forth the rights and preferences of the Series C Shares shall have been duly adopted by the Company by all necessary corporate action of its shareholders and the Board of Directors and shall have been submitted for filing with the Registrar of Companies of the Cayman Islands.

 

7.9.          Execution of the Restated Shareholders Agreement.  The Company and the other parties (other than the Investors) shall have executed and delivered to the Investors the Restated Shareholders Agreement.

 

7.10.        No Material Adverse Effect.  There shall have been no Material Adverse Effect on any Group Company or any subsidiary or Affiliate of any Group Company since the Balance Sheet Date.

 

7.11.        Opinion of Company Counsel. The Investors shall have received from the PRC and Cayman Islands counsels to the Company legal opinions addressed to the Investors, dated as of the Closing Date substantially in the form of Exhibit F and Exhibit G attached hereto.

 

8.             MISCELLANEOUS

 

8.1.          Governing Law and Dispute Resolution.

 

(a)           In the event of any dispute arising out of or in connection with this Agreement, including any question regarding its breach, existence, validity, or termination (“Dispute”), the parties shall in good faith attempt to resolve such Dispute as soon as practicable after the complaining party provides notice of such Dispute.  In the event that the Dispute is not resolved between the parties within five (5) business days after receipt of such notice, on the request of the party raising the Dispute, the Dispute shall be referred to and finally resolved by arbitration under the Rules of Arbitration of the International Chamber of Commerce (“ICC”) then in effect.  There shall be three arbitrators, one nominated by the initiating party and the second nominated by the other party, each within fifteen (15) days of receipt of the request for arbitration; the third, who shall act as the chair of the arbitral tribunal, shall be nominated by the two selected arbitrators within twenty (20) days of the confirmation of the second arbitrator.  If any arbitrators are not nominated within these time periods, the ICC International Court of Arbitration shall make the appointment(s).  The place of arbitration shall be Hong Kong.  The language of the arbitral proceedings shall be English.

 

19

 

The arbitral tribunal shall apply the International Bar Association Rules on the Taking of Evidence in International Arbitration (2010).  The arbitrators may award any relief permitted under this Agreement and applicable law; however they may not award punitive, exemplary or multiple damages.  The award shall be rendered within eight (8) months from the selection of the chair of the arbitral tribunal, unless the parties agree to extend this time limit or the arbitral tribunal determines that the interest of justice so requires.  The award shall be final and binding upon the parties as from the date rendered, and shall be the sole and exclusive remedy between the parties regarding any claims, counterclaims, issues, or accounting presented to the arbitral tribunal.  This Agreement and the rights and obligations of the parties shall remain in full force and effect pending the award in any arbitration proceeding hereunder.  The parties agree that any party to this Agreement shall have the right to have recourse to and shall be bound by the Pre-arbitral Referee Procedure of the ICC in accordance with its Rules for a Pre-Arbitral Referee Procedure.

 

(b)           The parties hereto shall initially split the costs of arbitration evenly.  The prevailing party in arbitration shall be entitled to recover from the other party all costs, including of arbitration, and attorneys’ fees incurred in connection with the arbitration.

 

(c)           This Agreement is governed by, and all disputes arising out of or in connection with this Agreement shall be resolved in accordance with the internal laws of the State of New York.

 

8.2.          Successors and Assigns. Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto whose rights or obligations hereunder are affected by such amendments.  This Agreement and the rights and obligations herein may be assigned by each Investor to its Affiliate  without the written consent of any other parties hereto; provided, however, that the Investors shall not assign any of its rights or obligations herein to any Competitor of the Group Companies without the approval of a majority of the directors of the Company.  For the purpose of this Agreement, “Competitor” means, in the good faith determination made by the Board of the Directors: (i) any person (either individual, firm, corporation, partnership, trust, incorporated or unincorporated association, joint venture, joint stock company, limited liability company, or other entity of any kind) that is directly or indirectly engaged in the business or undertaking of providing VOD/download-centric services in China in competition with the business of the Group Companies or any other activity in competition with the Company in China and is not an Affiliate of any Group Company, and (ii) any shareholder of such persons except for a shareholder holding less than 3% of the outstanding shares of such person.  This Agreement and the rights and obligations herein may not be assigned by the Company without the written consent of the Investors.

 

8.3.          Entire Agreement.  This Agreement and the other Transaction Agreements and the schedules and exhibits hereto and thereto, which are hereby expressly incorporated herein by this reference, constitute the entire understanding and agreement between the parties with regard to the subjects hereof and thereof; provided, however, that nothing in this Agreement or related agreements shall be deemed to terminate or supersede the provisions of any confidentiality and nondisclosure agreements executed by the parties hereto prior to the date hereof, which agreements shall continue in full force and effect until terminated in accordance with their respective terms.

 

8.4.          Notices. Except as may be otherwise provided herein, all notices, requests, waivers and other communications made pursuant to this Agreement shall be in writing and 

 

20

 

shall be conclusively deemed to have been duly given (a) when hand delivered to the other party, upon delivery; (b) when sent by facsimile at the number set forth in Exhibit D hereto, upon receipt of confirmation of error-free transmission; (c) seven (7) Business Days after deposit in the mail as air mail or certified mail, receipt requested, postage prepaid and addressed to the other party as set forth in Exhibit D; or (d) three (3) Business Days after deposit with an overnight delivery service, postage prepaid, addressed to the parties as set forth in Exhibit D  with next Business Day delivery guaranteed, provided that the sending party receives a confirmation of delivery from the delivery service provider.

 

Each person making a communication hereunder by facsimile shall promptly confirm by telephone to the person to whom such communication was addressed each communication made by it by facsimile pursuant hereto but the absence of such confirmation shall not affect the validity of any such communication.  Any party hereto may change or supplement the addresses given above, or designate additional addresses, for purposes of this Section 8.4 by giving, the other party written notice of the new address in the manner set forth above.

 

8.5.          Amendments and Waivers.  Any term of this Agreement may be amended and waived only with the written consent of the Investors, on the one hand, and the Company, on the other hand.  Any amendment or waiver effected in accordance with this Section 8.5 shall be binding upon all of the parties hereto, and their respective assigns.

 

8.6.          Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party hereto, upon any breach or default of any other party hereto under this Agreement, shall impair any such right, power or remedy of such former party, nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of any similar breach of default thereafter occurring.  Any waiver, permit, consent or approval of any kind or character on the part of any party hereto of any breach of default under this Agreement or any waiver on the part of any party hereto of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing.  All remedies, either under this Agreement, or by law or otherwise afforded to the parties hereto, shall be cumulative and not alternative.

 

8.7.          Rights of Investors.  Each Investor, in its sole and absolute discretion, may exercise or refrain from exercising any rights or privileges that such Investor may have pursuant to the Transaction Agreements, the agreements contemplated thereby, or at law or in equity, and the Investors shall not, except as required by law or the Restated Articles, incur or be subject to any liability or obligation to the Company or holder of securities of the Company or any other person, by reason of exercising or refraining from exercising any such rights or privileges.

 

8.8.          Interpretation; Titles and Subtitles. This Agreement shall be construed according to its fair language.  The rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be employed in interpreting this Agreement.  The titles of the sections and subsections of this Agreement are for convenience of reference only and are not to be considered in construing this Agreement.  Unless otherwise expressly provided herein, all references to Sections and Exhibits herein are to Sections and Exhibits of this Agreement.

 

8.9.          Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together shall constitute one instrument.

 

21

 

8.10.        Severability. If any provision of this Agreement is found to be invalid or unenforceable, then such provision shall be construed, to the extent feasible, so as to render the provision enforceable and to provide for the consummation of the transactions contemplated hereby on substantially the same terms as originally set forth herein, and if no feasible interpretation would save such provision, it shall be severed from the remainder of this Agreement, which shall remain in full force and effect unless the severed provision is essential to the rights or benefits intended by the parties.  In such event, the parties shall use best efforts to negotiate, in good faith, a substitute, valid and enforceable provision or agreement which most nearly effects the parties’ intent in entering into this Agreement.

 

8.11.        Confidentiality and Non-Disclosure.  The parties hereto agree to be bound by the confidentiality, non-disclosure and non-compete provisions of Section 7 of the Restated Shareholders Agreement.

 

8.12.        Further Assurances.  Each party shall from time to time and at all times hereafter make, do, execute, or cause or procure to be made, done and executed such further acts, deeds, conveyances, consents and assurances without further consideration, which may reasonably be required to effect the transactions contemplated by this Agreement.

 

8.13.        Expenses.  The Company and the Investors shall bear their respective legal and accountants’ fees and expenses with respect to this Agreement and the transactions contemplated hereby.

 

8.14.        Termination.  Unless extended mutually by written agreement of the parties, this Agreement may be terminated by any party hereto after the sixtieth (60th) day following the date of this Agreement, by written notice to each of the other parties, if the Closing has not occurred on or prior to such date.  Such termination under this Section 8.14 shall be without prejudice to any claims for damages or other remedies that the parties may have under applicable law.

 

8.15.        Supremacy.  In the event that there is a conflict between the provisions of this Agreement and those of the other Transaction Agreements and to the extent permitted by the applicable laws, the provisions of this Agreement shall prevail and, if so reasonably required by any parties hereto, the parties shall procure that any other relevant Transaction Agreement shall be amended as soon as reasonably practicable in order that such conflict be removed.

 

8.16.        Remedy.  The Investors should give written notice to the Company if the Investors become aware of the Company’s breach of any representation or warranty made by the Company in the Transaction Agreements or any failure by the Company to perform or comply with any covenant or agreement contained in the Transaction Agreements which adversely affect the Investors’ interests.  The Company shall remedy such breach or non-performance within 30 days after it receives written notice from the Investors.  If the Company fails to do so within such period, such breach and non-compliance will be considered a default, which shall entitle the Investors to seek damages or other remedies under applicable law.

 

- [REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK] -

 

22

 

IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

	
 
    	
COMPANY:
    
	
 
    	
 
    
	
 
    	
XUNLEI LIMITED
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/ Shenglong Zou
    
	
 
    	
Name:
    	
Shenglong Zou
    
	
 
    	
Title:
    	
Chief   Executive Officer
    

 

 

IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

 

	
 
    	
INVESTOR:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
RW INVESTMENTS LLC
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/   Paula M. Wardynski
    
	
 
    	
Name:
    	
Paula   M. Wardynski
    
	
 
    	
Title:
    	
Secretary   and Treasurer
    

 

 

IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized representatives to execute this Agreement as of the date and year first above written.

 

 

	
 
    	
INVESTOR:
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
CRP Holdings   Limited
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
/s/   Bao Fan
    
	
 
    	
Name:
    	
Bao   Fan
    
	
 
    	
Title:
    	
Chief   Executive Officer
    

 

 

LIST OF EXHIBITS

 

	
SCHEDULE   A
    	
Subsidiaries
    
	
 
    	
 
    
	
SCHEDULE   B
    	
Schedule   of Investors
    
	
 
    	
 
    
	
Exhibit A
    	
Capitalization Table Immediately Following   Closing
    
	
 
    	
 
    
	
Exhibit B
    	
Restated   Articles
    
	
 
    	
 
    
	
Exhibit C
    	
Restated   Shareholders Agreement
    
	
 
    	
 
    
	
Exhibit D
    	
Notices
    
	
 
    	
 
    
	
Exhibit E
    	
Key   Employees of the Group Companies
    
	
 
    	
 
    
	
Exhibit F
    	
Form of   PRC Legal Opinion
    
	
 
    	
 
    
	
Exhibit G
    	
Form of   Cayman Islands Legal Opinion
    
	
 
    	
 
    
	
Exhibit H
    	
Form of   Power of Attorney
    
			

 

 

SCHEDULE A

 

Subsidiaries

 

Giganology (Shenzhen) Limited (千兆科技(深圳)有限公司)

 

Shenzhen Xunlei Networking Technologies Co., Ltd. (深圳市迅雷网络技术有限公司)

 

Shenzhen Fengdong Networking Technologies Company Limited (深圳市烽动网络技术有限公司)

 

Xunlei Games Development (Shenzhen) Co., Ltd. (深圳市迅雷游戏开发有限公司)

 

Xunlei Software (Nanjing) Co., Ltd. (南京迅雷软件有限公司)

 

Xunlei Software (Shenzhen) Co., Ltd. (深圳市迅雷软件有限公司)

 

Xunlei Networking (Beijing) Co., Ltd. (北京迅雷网络有限公司)

 

155 Networking (Shenzhen) Co., Ltd. (深圳市壹伍伍网络技术有限公司)

 

 

SCHEDULE B

 

Schedule of Investors

 

	
Name of Investors
    	
 
    	
Number of Series C 
   Shares to be 
   Subscribed
    	
 
    	
Subscription Price 
   (US$)
    	
 
    
	
RW Investments LLC
    	
 
    	
5,613,699
    	
 
    	
US$
    	
29,400,000
    	
 
    
	
CRP Holdings Limited
    	
 
    	
114,565
    	
 
    	
US$
    	
600,000
    	
 
    

 

 

EXHIBIT A

 

Capitalization Tables Immediately Prior to and Following the Closing

 

 

EXHIBIT B

 

Restated Articles

 

 

EXHIBIT C

 

Amended and Restated Shareholders Agreement

 

 

EXHIBIT D

 

Notices

 

TO THE COMPANY:

 

11th Floor, Shuguang Tower,

South Area,

Nanshan District High-New Technology Park,

Shenzhen,

People’s Republic of China

Fax: (86 755) 2699 3074

Attention: Mr. Zou Shenglong

 

TO THE INVESTORS:

 

RW INVESTMENTS LLC

The address, telephone, fax, and email that is on file with the Company, as such information may be amended from time to time by such investor

 

CRP HOLDINGS LIMITED

The address, telephone, fax, and email that is on file with the Company, as such information may be amended from time to time by such investor

 

 

EXHIBIT E

 

Key Employees of the Group Companies

 

Zou Shenglong

Cheng Hao

Raymond Weimin Luo

Jun Zou

 

 

EXHIBIT F

 

Form of PRC Legal Opinion

 

 

EXHIBIT G

 

Form of Cayman Islands Legal Opinion

 

 

EXHIBIT H

 

FORM OF POWER OF ATTORNEY

 

授  权  委  托  书

 

	
委托人:
    	
姓        名:
    
	
 
    	
身份证号:
    
	
 
    	
地        址:
    
	
 
    	
邮        编:
    
	
 
    	
电        话:
    
	
 
    	
 
    
	
受委托人:
    	
姓        名:
    
	
 
    	
身份证号:
    
	
 
    	
地        址:
    
	
 
    	
邮        编:
    
	
 
    	
电        话:
    

 

委托人拟行使根据其于20    年    月      日与 [·], 一家根据[·]法律设立的公司(“境外公司”),签署之认股证书/期权协议而获得的认股权/期权。在满足认股证书/期权协议规定的相应条件的情况下,委托人将获得境外公司的                股普通股(占境外公司总股本的    %)。现就上述认股权/期权行使行为委托受委托人代为办理相关的外汇登记手续。

 

受委托人的代理权限为:代为提出申请,并办理有关声明、承认、变更或放弃的手续,领取有关通知、证明、文件等资料,以及其他一切与办理此次外汇登记相关的事宜。

 

 

委托人:                        (签字)

 

	
 
    	
二零      年      月     日

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}]]